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SUMMARY AND CONCLUSION 
 
 This chapter summarizes the major findings, limitations and implications in 
the field of nursing education, nursing practice, nursing administration, nursing 
research and recommendations for further research.  
 The main aim of the study was to assess the effect of dry cold application on 
pain perception and ecchymosis among patients receiving low molecular weight 
heparin. The dry cold application is an effective method in reducing pain perception 
and ecchymosis. 
  The proposed conceptual framework for the present study was Widen Bach¶s 
helping art of clinical nursing theory. Review of literature brought out many facts 
about effect of dry cold application among patients receiving low molecular weight 
heparin. The post test only control group design was used for the study.  
            The study was conducted in Sri Ramakrishna Hospital, Coimbatore. Total 
enumerative sampling technique was used to select the samples were randomly 
assigned to experimental group (n=13) and the control group (n=12). Dry cold 
application was given for 3 minutes on the LMWH injection site for the experimental 
group. Injection LMWH was administered subcutaneously to the experimental group 
and control group. The level of pain perception was assessed using numerical pain 
rating scale and the ecchymosis was assessed by using transparent ruler scale. 
Unpaired µW¶ WHVW ZDV XVHG WR ILQG RXW WKH HIIHFW RI dry cold application on pain 
perception and ecchymosis among patients receiving low molecular weight heparin. 
The findings of the study concluded that the effect of dry cold application on pain 
perception and ecchymosis among patients receiving low molecular weight heparin.   
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6. 1 Major Findings of the Study 
6.1.1 The majority of patients both 9 (69.23%) in experimental group and  
8 (66.67%) in control group were in the age group of above 51 years. 
6.1.2 In the experimental group majority, 10 (76.92%) patients were males. In the 
control group 6 (50%) patients were males and females respectively. 
6.1.3 The majority of patients both 6 (46.15%) in experimental group and  
5 (41.67%) in control group had high school education.  
6.1.4 The majority of patients both 11 (84.62%) in experimental group and  
9 (75%) in control group were married. 
6.1.5 The majority of patients both 13 (100%) in experimental group and  
10 (83.33%) in control group belonged to Hindu religion. 
6.1.6 In the experimental group majority, 9 (69.23%) patients were employed. In 
the control group 6 (50%) patients were employed and 6 (50%) patients were 
unemployed respectively.  
6.1.7 The majority of patients both 10 (76.92%) in experimental group and  
8 (66.67 %) in control group were diagnosed with CVA. 
6.1.8 The majority of patients both 8 (61.53%) in experimental group and  
8 (66.67%) in control group received Inj. Flothin 40 mg. 
6.1.9 All patients in the experimental and control group, received inj. LMWH twice 
a day. 
6.1.10 In the experimental group majority, 10 (76.92%) patients had other illness. In 
the control group 6 (50%) patients had other illness, 6 (50%) patients had no 
other illness such as DM, SHT, CCF, CRF, PVD etc.  
104 
 
6.1.11 Level of pain perception among patients receiving LMWH on right upper 
outer arm shows that in experimental group immediately after withdrawing 
needle, 13 (100%) patients had mild pain, after 4 hours and 8 hours  
13 (100%) patients had no pain respectively, whereas in the control group 
immediately after withdrawing needle 8 (66.67%) patients had moderate pain, 
after 4 hours, 8 (66.67%) patients had mild pain, and after 8 hours 6 (50%) 
patients had no pain and mild pain respectively.    
6.1.12 Level of pain perception among patients receiving LMWH on left upper outer 
arm reveals that in experimental group immediately after withdrawing needle 
12 (92.31%) patients had mild pain, after 4 hours and 8 hours 13 (100%) of 
patients had no pain respectively, whereas in control group immediately after 
withdrawing needle 8 (66.67%) patients had moderate pain, after 4 hours,  
10 (83.33%) patients had mild pain, and after 8 hours 7 (58.33%)  
patients had no pain. 
6.1.13 Level of pain perception among patients receiving LMWH on right thigh 
shows that in experimental group immediately after withdrawing needle,  
7 (53.85%) patients had mild pain, after 4 hours and 8 hours 13 (100%) 
patients had no pain respectively, whereas in control group immediately after 
withdrawing needle 10 (83.33%) patients had moderate pain, after 4 hours,  
7 (58.33%) patients had mild pain, and after 8 hours 9 (75%) patients had no 
pain. 
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6.1.14 Level of pain perception among patients receiving LMWH on left thigh shows 
that in experimental group immediately after withdrawing needle, 8 (61.54%) 
patients had mild pain, after 4 hours and 8 hours 13 (100%) patients had mild 
pain respectively, whereas in control group immediately after withdrawing 
needle 6 (50%) patients had moderate pain and severe pain respectively, after 
4 hours, 10 (83.33%) patients had mild pain, and after 8 hours 7 (58.33%) 
patients had no pain. 
6.1.15 Size of ecchymosis among patients receiving LMWH on right upper outer arm 
reveals that in the experimental group after 48 hours and 72 hours 13 (100%) 
patients had ecchymosis measuring 0-0.5 cm2, whereas in the control group 
after 48 hours, 9 (75%) patients had ecchymosis measuring 0-0.5 cm2, and 
after 72 hours, 8 (66.67%) patients had ecchymosis measuring 0-0.5 cm2.  
6.1.16 Size of ecchymosis among patients receiving LMWH on left upper outer arm 
reveals that in the experimental group after 48 hours and 72 hours 13 (100%) 
patients had ecchymosis measuring 0-0.5 cm2, whereas in the control group 
after 48 hours, 10 (83.34%) patients had ecchymosis measuring 0-0.5 cm2, 
and after 72 hours, 8 (66.67%) patients had ecchymosis measuring 0-0.5 cm2. 
6.1.17 Size of ecchymosis among patients receiving LMWH on right and left thigh 
reveals that in the experimental and control group, after 48 hours and 72 hours 
13 (100%) patients had ecchymosis measuring 0-0.5 cm2.  
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6.1.18 Effect of dry cold application on pain perception, immediately after 
withdrawing needle, it was identified that, the mean score and standard 
deviation of experimental group was 0.439 and 0.555 respectively and control 
group was 1.861 and 2.155 respectively with the mean difference of 1.422. 
&DOFXODWHG µW¶ value was 2.205, which was greater than the table value  
(tv= 2.07, df=23) at 0.05 level of significance. Pain perception assessed after  
4 hours, it was identified that, the mean score and standard deviation of 
experimental group was 0 and control group 0.294 and 0.359 respectively 
ZLWKWKHPHDQGLIIHUHQFHRI&DOFXODWHGµW¶YDOXHZDVZKLFKZDV
greater than the table value (tv= 2.07, df=23) at 0.05 level of significance. Pain 
perception assessed after 8 hours, it was identified that, the mean score and 
standard deviation of experimental group was 0 and the control group was 
DQGUHVSHFWLYHO\ZLWKWKHPHDQGLIIHUHQFHRI&DOFXODWHGµW¶
value was 2.912, which was greater than the table value (tv= 2.07, df=23) at 
0.05 level of significance. Hence it shows there is a significant difference in 
the level of pain perception among patients receiving LMWH in immediately 
after withdrawing needle, after 4 hours and after 8 hours in the experimental 
and control group. Thus the research hypothesis H1: There will be a 
significant difference in the level of pain perception between the experimental 
group and control group after dry cold application among patients receiving 
low molecular weight heparin is accepted. 
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6.1.19  Effect of dry cold application on ecchymosis, 48 hours after the day of 
injection, it was identified that, the mean score and the standard deviation of 
experimental group was 0.003 and 0 respectively and control group was 0.069 
DQGUHVSHFWLYHO\ZLWKWKHPHDQGLIIHUHQFHRI&DOFXODWHGµW¶Yalue 
was 2.129, which was greater than the table value (tv= 2.07, df=23) at 0.05 
level of significance. Ecchymosis assessed 72 hours after the day of injection, 
it was identified that, the mean score and the standard deviation of 
experimental group was 0.001 and 0 and control group was 0.109 and 0.175 
UHVSHFWLYHO\ ZLWK WKH PHDQ GLIIHUHQFH RI  &DOFXODWHG µW¶ YDOXH ZDV
2.118, which was greater than the table value (tv= 2.07, df=23) at 0.05 level of 
significance. Hence it shows there is a significant difference in the size of 
ecchymosis among patients receiving LMWH in 48 hours and 72 hours after 
the day of injection. Thus the research hypothesis H2: There will be a 
significant difference in the size of ecchymosis between the experimental 
group and control group after dry cold application among patients receiving 
low molecular weight heparin is accepted. 
6.2  Limitation 
6.2.1 Generalization was not possible due to small sample size (n=25). 
6.2.2  The second dose ecchymosis could not be assessed in the right and left thigh 
 because the patients were discharged after 5 days. 
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6.3  Recommendations 
6.3.1    The similar study can be undertaken with large samples to show strong        
statistical association.   
6.3.2 A similar study can be conducted among the patients receiving various routes 
of injections such intramuscular, intravenous and intradermal.  
6.3.3 A comparative study can be conducted to assess the level of pain and 
ecchymosis among patients receiving low molecular weight heparin before 
and after of dry cold application.  
6.3.4  All staff nurses have to be trained to implement the dry cold application 
before administering LMWH to reduce the level of pain perception and 
ecchymosis.  
6.4  Nursing implications 
 The finding of the study has several implications for nursing education, 
nursing administration, nursing practice and nursing research. 
6.4.1  Nursing education 
 Nursing students should be educated on recent practice and trends of 
administration of low molecular weight heparin. Nursing curriculum should be 
equipped with knowledge and skill to prepare efficient nurses to provide quality 
nursing care. 
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6.4.2  Nursing administration 
           The nurse administrator should look into the need for organizing in-service and 
continuing nursing education programs for staff nurses in order to update their 
knowledge regarding the use of dry cold application. Nursing administrators can 
introduce dry cold application as an evidenced based practice protocol. Nurse 
administrators should communicate this knowledge to the clinical staff and ensure 
practice of dry cold application for patients getting LMWH.  
6.4.3  Nursing practice 
 Nurses play a vital role in the health care delivery system, who works in the 
immediate environment with the patients and has all the opportunity to identify the 
need and problems. Result of the present study strongly recommended that dry cold 
application was effective on pain perception and ecchymosis. Hence the nurses 
should be trained for dry cold application prior to administration of injection low 
molecular weight heparin to reduce pain perception and ecchymosis.  
6.4.4  Nursing research 
 Selected measures can be applied to reduce the pain perception and 
ecchymosis after administration of injection LMWH. Hence nurse researcher should 
focus on well-designed clinical trials on pain perception and ecchymosis after 
administering various injections in various settings. The finding of the present study 
is helpful for the nursing professionals to conduct further studies to find out the 
effectiveness of various techniques and therapies on pain perception and ecchymosis.  
It adds valuable knowledge which can be used as evidence based practice. 
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6.5 Conclusion 
The patients receiving LMWH experienced pain and develop ecchymosis. The 
study was conducted to find the effect of dry cold application on pain perception and 
ecchymosis among patients receiving low molecular weight heparin. Dry cold 
application prior to administration of LMWH has shown to reduce pain perception 
and ecchymosis. Therefore the dry cold can be used as a measure in reducing 
injection LMWH induced pain perception and ecchymosis. This study proves that the 
dry cold application is effective in reducing pain perception and ecchymosis among 
patients receiving low molecular weight heparin.  
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TOOL TO ASSESS PAIN PERCEPTION AND ECCHYMOSIS 
AMONG PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN 
                                                           Section ± A 
Demographic Variables: 
Sample Number: 
1.  Age    
 a) Below 30 years b) 30-40 years          
 c) 41-50 years          d) Above 51 years                                                 
2.  Gender                    
 a) Male                     b) Female 
3.  Educational status                               
 a) Illiterate             b) Primary school       
 c) High school                                           d) Higher secondary     
 e) Graduate   
4.  Marital status             
 a) Single                   b) Married              
 c) Widow                  d) Divorce                    
5.   Religion                                         
 a) Hindu                        b) Christian               
 c) Muslim          d) Others 
6.  Occupation  
 a) Employed           b) Unemployed          
 
Section-B 
Clinical Variables: 
1.  Diagnosis  
 a) Stroke                  b) DVT                         
 c) CVT                         d) Others                         
2.  Name of the injection and dose          
 a) Inj. Lupenox 0.4ml        b) Inj. Flothin 0.4ml      
  c) Inj. Enox 0.4ml            d) Inj. Clexane 0.4 ml          
3.  Frequency of Inj. LMWH 
 a) Twice a day          b) Once in a day  
4.  Any other illness 
 a) Yes                      b) No 
,I\HVVSHFLI\««  
 
 
 
 
 
 
                                                                 Section ± C 
Numerical Pain Rating Scale:  
 
 
 
 
The score is interpreted as: 
x 0: No pain  
x 1-3: Mild pain 
x 4-6: Moderate pain 
x 7-8: Severe pain 
x 9-10: Unbearable pain        
 
 
 
 
 
 Section ± D 
Transparent Ruler Scale 
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Abstract  
 The main aim of the study was to assess the effect of dry cold application on 
pain perception and ecchymosis among patients receiving low molecular weight 
heparin in Sri Ramakrishna hospital, Coimbatore. The research design used for the 
present study was a true experimental posttest only control group design. Total 
enumerative sampling technique was used to select 25 samples. The samples were 
randomly assigned to experimental group (n=13) and the control group (n=12). Dry 
cold application was given for 3 minutes on the LMWH injection site for the 
experimental group. Injection LMWH was administered subcutaneously to the 
experimental group and control group. Pain perception was assessed using numerical 
pain rating scale and ecchymosis was assessed by using transparent ruler scale. 
Descriptive and inferential statistical techniques were used to analyze the collected 
GDWD8VLQJXQSDLUHGµW¶WHVWWKHHIIHFWRIGU\FROGDSSOLFDWLRQRQSDLQSHUFHSWLRQ was 
analyzed immediately after withdrawing the needle, after 4 hours and 8 hours  
(t = 2.205, 2.827 and 2.912 respectively, df = 23, p < 0.05) and ecchymosis was 
analyzed after 48 hours and 72 hours (t = 2.129 and 2.118 respectively, df = 23,  
p < 0.05). Hence it is concluded that application of dry cold is effective in reducing 
the level of pain perception and ecchymosis among patients receiving low molecular 
weight heparin. 
 
1 
 
INTRODUCTION 
  
 Health is the level of functional or metabolic efficiency of a living 
organism. In humans it is the ability of individuals or communities to adapt and 
self-manage when facing physical, mental or social challenges (Webster, 1913). 
Health is a state in which relative equilibrium of body and function which results 
from its successful dynamic adjustment to forces tending to disturb it. It is not a 
passive interplay between body substance and forces impinging upon it but an 
active response of body forces working towards readjustment. (Park, 2015)  
            Wellness is an active process of becoming aware of and making choices 
toward a more successful existence (National Wellness Institute, 2013). Wellness 
is an active, lifelong process of becoming aware of choices and making decisions 
toward a more balanced and fulfilling life. Wellness involves choices about our 
lives and our priorities that determine our lifestyles. (Arizona State University, 
2013) 
       In Biological Medicine, illness is defined as a loss of regulatory capacity: 
that is, the inability to correctly respond to a wide variety of internal, 
environmental and lifestyle factors. (Rau, 2013) 
            Neurological problems pose a serious threat to the population and health 
care resources. Globally they are the number one cause of death. Stroke is the 
third leading cause of death in the United States. (Gourie-Devi, 2008) 
            Worldwide, 20 million people suffer from stroke each year, five million 
die and another five million are disabled. It is estimated that one in six people will 
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suffer a stroke in their lifetime. In India, 1.5 million suffer from stroke every year 
and 3,000 to 4,000 are affected each day. Stroke causes more deaths in the country 
than malaria, tuberculosis, and HIV combined. (Masand, 2013) 
 Stroke is the primary cerebro vascular disorder in the United States. 
Approximately 7,80,000 people experience a stroke each year in the United States. 
Approximately 6,00,000 of these are new stroke and 1,80,000 are recurrent stroke. 
Three adults suffer from a stroke every minute in India (Mumbai) and around 5 
million people are disabled globally due to the brain attack each year. Yet, half the 
residents of metros in India are unaware of stroke and their link to the brain. 
Stroke is divided into two types; they are ischemic stroke and hemorrhagic stroke. 
(Masand, 2013) 
            Early treatment with thrombolytic therapy for ischemic stroke results in 
fewer stroke symptoms and less loss of function. Currently approved thrombolytic 
therapy has a treatment window of only 3 hours after the onset of stroke. 
(Suddarth & Brunner, 2014) 
            Thrombolytic agents are used to treat ischemic stroke by dissolving the 
blood clot. Anticoagulation for primary stroke prevention after myocardial 
infarction (MI) is recommended in patients with the following risk factors: 
persistent or paroxysmal atrial fibrillation, left ventricular thrombus, left 
ventricular aneurysm, left ventricular ejection fraction (LVEF<25%).  
(Cruz-Flores, 2015) 
 The possibility of developing a deep vein thrombosis (DVT) is one major 
complication for the patient population with damaged blood vessels, decreased 
circulation problems, or restricted mobility. Use of a low molecular weight 
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heparin (LMWH), as part of the patients anticoagulation therapy, is one 
intervention that can be implemented to prevent the formation of thrombi (clots) 
that cause DVTs, pulmonary emboli, strokes and myocardial infarctions                  
(Suddarth & Brunner, 2014). These complications would not only cause harm to 
the patient but also increase the resources needed to treat and rehabilitate that 
individual. (Chenicek, 2004)  
LMWHs are defined as heparin salts having an average molecular weight 
of less than 8000 Daltons and for which at least 60% of all chains have a 
molecular weight less than 8000 Daltons. Heparin derived from natural sources, 
mainly porcine intestine or bovine lung, can be administered therapeutically to 
prevent thrombosis. These are obtained by various methods of fractionalization or 
depolymerisation of polymeric heparin. However, the effects of natural or 
unfractionated heparin are more unpredictable than LMWH. (John, 2013) 
            Subcutaneous low molecular weight heparin (LMWH) is frequently 
prescribed for stroke, infarct, deep vein thrombosis and other cardiovascular 
disorders. Low molecular weight heparin (LMWH) is a class of medication used 
as an anticoagulant. They are administered subcutaneously in fixed doses; once or 
twice daily. (Melba & Priyalatha, 2009) 
            The low molecular weight heparin poses many side effects such as pain, 
fever, confusion, nausea, hemorrhage, hypochromic anemia, thrombocytopenia, 
bleeding, ecchymosis, injection site hematoma, edema and peripheral edema 
(Skidmore-Roth, 2009). One of the most commonly encountered adverse 
physiological responses to this intervention is the formation of hematomas at the 
injection site. (Batra, 2014) 
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Health systems need to be strengthened to deliver better care for people 
with neurological disorders. Primary care is the only access to medical treatment 
and use low-technology interventions. (United National Report, 2007) 
            Ice is a therapeutic agent used in medicine as an integral part of injury 
treatment and rehabilitation. The use of ice pack is widespread because of their 
effectiveness, convenience, low cost, and ease of transportation. Ice packs can be 
made with any form of ice; however, 2 commonly used forms are cubed ice and 
crushed ice. Ice is believed to control pain by inducing local anaesthesia around 
the treatment area. Investigators have also shown that it decreases oedema, nerve 
conduction velocities, cellular metabolism, and local blood flow. (Sheikh, 2010) 
            A simple and inexpensive therapy, dry cold application has been accepted 
for decades as an effective non pharmacologic intervention for pain management. 
Application of ice is effective in orthopaedic procedures. (Yagiz, 2006) 
            A dry cold application can be made by filling an ice bag with crushed ice 
and wrapping it in a towel or washed cloth which will be colder than moist 
applications. Dry cold also prevents moisture from coming in direct contact with 
the skin. (Pamela, 2005) 
The physiological effects of cold application are peripheral 
vasoconstriction, decreased capillary permeability, oxygen consumption, local 
metabolism, muscle tone, blood flow, lymph flow, motility of leucocytes and 
increased blood viscosity. (Nancy, 2012) 
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1.1 Need for the study 
 The spectrum of neurological disorders includes epilepsy, stroke, 
headache, $O]KHLPHU¶V disease and other dementias, 3DUNLQVRQ¶V disease, multiple 
sclerosis, brain injuries, neuro infections etc. Stroke is the second most common 
cause of mortality and a major cause of disability. Up to 1 billion people, nearly 
RQH LQ VL[ RI WKH ZRUOG¶V population, suffers from neurological disorders and                       
6.8 million dying each year. (United National Report, 2007) 
            Stroke is a major public health concern. An estimated 7, 00,000 persons in 
the United States and 50,000 in Canada suffer a stroke annually. Stroke is also a 
leading cause of serious long term disability. With an aging population, a further 
increase in stroke incidence can be expected. (Devi, 2009) 
            The devastating stroke consequences have enormous personal, social and 
economic impact on oneself and the society. Stroke is the second leading cause of 
death worldwide. (Neurol., et al, 2012) 
 After an initial stroke, 22% of men and 25% of women will die within  
1 year. The percentage is higher for people aged 65 and older. Of those who 
survive, 50% to 70% will be functionally independent, and 15% to 30% will live 
with permanent disability. Twenty percent will require long-term care after  
3 months. Common long term disabilities include hemiparesis, inability to walk, 
complete or partial dependence in activities of daily living (ADLs), aphasia, and 
depression. (Caplan, 2015)  
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 All age groups are affected, mainly elderly above 60 years of age. In India 
according to the 2001 census there are 77 million people above the age of 60 years 
and it is expected that by 2025 there will be a huge increase to 177 million with 
consequent significant rise in age-related disorders such as cerebro vascular 
disorders, Parkinson's disease and dementia. (Gourie-Devi, 2008) 
            Stroke is among the top 5 leading causes of death in India and WHO 
predicts that by 2015, India will report 1.6 million cases of stroke annually, at 
least one-third of whom will be disabled and by 2050, 80% of stroke cases in the 
world would occur in low and middle income countries mainly India and China. 
(Masand, 2013) 
            Therapeutic strategies such as stroke unit care and treatments including 
tissue plasminogen activator (tPA) have been developed to treat acute stroke more 
effectively and lessen the amount of disability that the disease carries. 
Anticoagulation and antithrombotic therapies remain the main agents for stroke 
prevention. (Demarin., et al, 2013). 
            Anticoagulation has proved to be an important treatment modality in 
preventing thrombus formation. Anticoagulants are often, but incorrectly, referred 
to as blood thinners. They work by decreasing the formation of additional blood 
clots. Heparin and low molecular weight heparin are anticoagulants.  
(Caplan, 2015) 
 Subcutaneous administration of anticoagulant heparin sodium is a 
frequently performed nursing intervention. The role of nurses attempting to 
minimize hematoma formation and patient discomfort during the administration of 
LMWH. (Batra, 2014) 
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            Low molecular weight heparin poses many side effects. Local side effects 
include pain, erythema and ecchymosis. Hemorrhagic side effects have occurred 
in 3% to 7% of patients. Rarely painful red indurations and necrotic ulcerations at 
the injection site have been reported. Ecchymosis is one of the common side 
effects associated with LMWH. Ecchymosis is the injury to biological tissue and 
capillary damage occurs, allowing blood to seep into surrounding tissue. The 
incidence of bleeding complications was higher in older patients (> 65 years) than 
younger patients. (Melba & Priyalatha, 2009) 
 Another side effect which is commonly associated with LMWH is pain at 
the injection site. Pain is one of the major reasons that persons seek health care. 
Statistics reveals that about $1 billion is spent each year for relief of pain.             
(Masand, 2013) 
            Pain and bruising associated with these injections are problematic for both 
patients and nurses. 7KH SDLQ KDV D QHJDWLYH HIIHFW RQ RQH¶V VHOI FRQFHSWThey 
may lead to anxiety, discomfort, disruption of body image, and the rejection of 
treatment in patients. So it is becoming an important issue of concern in the 
nursing field. (Fathi., et al, 2014) 
Cold application is the application of a cold agent cooler than skin either in 
a moist or dry form, on the surface of the skin, to reduce pain and body 
temperature, to anaesthetize an area, to control the haemorrhage, to prevent 
gangrene, to prevent oedema and reduce inflammation. (Nancy, 2012) 
 Dry cold can be applied by means of an ice bag, moist cold by means of 
towel soaked in ice water, cold hydro collator packs, or immersion in a bath or 
under running water. (Lewis., et al, 2015) 
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            Uses of dry cold application in reducing the pain perception and 
progression of ecchymosis have proved to be important. Dry cold application is a 
simple and inexpensive therapy which has been accepted for decades as an 
effective non pharmacologic intervention for pain management and progression of 
ecchymosis. (Melba & Priyalatha, 2009)  
            The researcher during her clinical experiences came across incidence of 
pain and ecchymosis at LMWH site and patients complaining of these side effects. 
Researcher also felt the need for better management of side effects which could be 
easily accessible and economical for the patients. Dry cold application appears to 
be a cheaper and easily available therapy to reduce pain and ecchymosis. Hence 
the researcher has selected study to evaluate effect of dry cold application on pain 
perception and ecchymosis among patients receiving injection LMWH. 
1.2 Statement of the Problem 
           Effect of Dry Cold Application on Pain Perception and Ecchymosis among 
Patients Receiving Low Molecular Weight Heparin at Selected Hospital, 
Coimbatore. 
1.3 Objectives 
1.3.1 To assess the pain perception and ecchymosis among patients receiving 
 low molecular weight heparin. 
1.3.2 To evaluate the effect of dry cold application on pain perception and 
 ecchymosis among patients receiving low molecular weight heparin.  
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1.4 Operational definition 
1.4.1  Effect 
            It is the reduction of pain perception and ecchymosis after dry cold 
application which is assessed by numerical pain rating scale and transparent ruler 
scale. 
1.4.2    Dry cold application 
            It refers to the application, of ice cubes filled in an ice cap over the low 
molecular weight heparin (LMWH) injection site, 3 minutes prior to its 
administration, for 5 consecutive days.  
1.4.3    Pain perception 
            It refers to the unpleasant sensation during the administration of LMWH 
injection which is assessed immediately after withdrawal of the needle, 4 hours 
and 8 hours of injection by using numerical pain rating scale. 
1.4.4    Ecchymosis 
 It refers to the discolouration of the skin caused due to the escape of blood 
into the tissues from ruptured blood vessels following subcutaneous injection 
(LMWH). This is assessed 48 hours and 72 hours after the day of injection by 
using transparent ruler scale. 
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1.5 Hypothesis 
            H1 :  There will be a significant difference in the level of pain perception
 between the experimental group and control group after dry cold 
 application among patients receiving low molecular weight 
 heparin. 
 H2 :  There will be a significant difference in the size of ecchymosis 
between the experimental group and control group after dry cold 
application among patients receiving low molecular weight 
heparin. 
1.6       Conceptual framework 
            Conceptual framework of this study was based on the helping art in 
clinical nursing theory by Ernestine Widen Bach in 1964. The theory focuses on 
three concepts such as identification, ministration and validation. According to 
Widen Bach, nursing practice, FRQVLVW RI LGHQWLI\LQJ D FOLHQW¶V QHHG IRU KHOS
ministering the needed help and validating the needed help. 
(i) Identification 
            Identification involves viewing a client as an individual with unique 
H[SHULHQFHV DQG XQGHUVWDQGLQJ WKH FOLHQW¶V SHUFHSWLRQ RI WKH FRQGLWLRQ ,Q WKLV
study, identification refers to the selection of patients who are receiving Inj. 
LMWH based on the demographic variables including age, gender, educational 
status, marital status, religion, occupation and clinical variables including 
diagnosis, name of the injection and dose, frequency of injection LMWH and 
presence of any other illness. 
11 
 
(ii) Ministration 
 Ministration refers to the provision of needed help. In this study, the 
researcher randomly assigned to the samples into experimental group (n=13) and 
the control group (n=12). Dry cold application was given for 3 minutes on the 
LMWH injection site for the experimental group. Injection LMWH was 
administered subcutaneously to the experimental group and control group. The 
pain perception was assessed immediately after withdrawing needle, 4 hours and          
8 hours by using numerical pain rating scale and ecchymosis was assessed                    
48 hours and 72 hours after the day of injection by using transparent ruler scale 
for both experimental group and control group.  
(iii) Validation 
            Validation refers to the collection of evidence that shows that the clients 
needs have been met and the functional ability has been restored as a result of 
ministration. Here the validation refers to the assessed evaluation of the effect of 
dry cold application on pain perception and ecchymosis in the experimental group 
and the control group by using numerical pain rating scale and transparent ruler 
scale. 
12
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1.7  Projected outcome 
  Dry cold application on the injection site will reduce pain perception and 
ecchymosis among patients receiving injection low molecular weight heparin.  
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REVIEW OF LITERATURE 
 Review of literature is an evaluative report of information found in the 
literature related to selected area of the study. The review describes, summarizes, 
evaluates and clarifies a theoretical base for the research and helps to determine 
the nature of research. 
 For the present study, related literature was reviewed and organized in the 
following manner. 
2.1     Literature related to low molecular weight heparin. 
2.2  Literature related to effect of cold application 
2.3  Literature related to effect of dry cold application on pain perception and 
 ecchymosis. 
2.1  Literature Related to Low Molecular Weight Heparin 
            Dadaeen., et al (2015) conducted a study on the effect of duration of 
subcutaneous injection on the extent of bruising and pain intensity at injection 
sites among patients receiving enoxaparin sodium. Convenience sampling was 
used. For each patient, two subcutaneous injection methods were performed:  
10-second subcutaneous injection on the right side of the abdomen as the control 
group and 30-second subcutaneous injection on the left side of the abdomen as the 
intervention group. At the first, injection site was determined using simple random 
assignment. The bruising area was analyzed by using computer software 48 and 
72 hours after each injection. Also, pain intensity was measured by Numeric 
Rating Scale (NRS) immediately after each injection. Data were analyzed using 
non-parametric tests. Statistical significance was set at P<0.05. The mean and 
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standard error of bruising in 10 and 30-second injections after 48 hours were 
45.53 ± 6.35 and 23.69 ± 3.27 mm2, respectively. After 72 hours, these measures 
were obtained as 26.45 ± 4.70 and 14.76 ± 3.52 mm2, respectively (P<0.001). 
Besides, the median and interquartile range of pain intensity scores in 10 and  
30-second injections were 5 (4 - 7) and 3 (1.25 - 5), respectively, (P<0.001). The 
results indicated that increasing the length of enoxaparin subcutaneous injection 
reduced the extent of bruising and pain intensity at the injection sites.  
 Fathi., et al (2014) conducted a study to compare the effects of air locks 
and duration of pain and bruising caused by the subcutaneous heparin injection. 
Quasi-experimental study was done on 35 patients treated with subcutaneous 
heparin. For each patient, two injections of 10 seconds without the use of an air 
lock (the usual method), and 30 seconds with the use of air lock (case study 
method) were carried out in the abdomen on the right and left, randomly. The 
interval between injections was 12 hours. Bruising 24 and 48 hours after injection 
was measured using a plastic ruler and pain was measured using the VAS scale 
immediately and 24 hours after injection. Size of the bruises caused by the 
injections in study method was significantly less than the size of the bruises 
FDXVHGE\LQMHFWLRQLQWKHXVXDOPHWKRG3$YHUDJHVL]HRIWKHEUXLVHVLQWKH
usual method at 24 and 48 hours after injection of subcutaneous heparin were 
1.791 and 1.817 respectively, and 0.854 in study method. Increasing the injection 
duration to 30 seconds and use of an air lock heparin subcutaneous injection is 
recommended. 
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Sari., et al (2014) conducted a study on slow versus fast subcutaneous 
heparin injections for prevention of bruising and site-pain intensity. Samples who 
met the inclusion criteria, involving 50 participants with a mean age of  
55.25 (± 12.37) years were selected. Each participant had two injections, one in 
the left side and one in right side of the abdomen. One of these was injected 
slowly (intervention) and the other was injected fast (control). The second 
injection was 12 hours after the first injection. The duration of fast injection was 
10 seconds and the duration of slow injection was 30 seconds. The mean pain 
intensity was 13.9 ± 17.1 mm with the slow injection and 20.6 ± 22.3 mm with the 
fast injection (P<0.001). In addition the bruising sizes were smaller with slow 
injections compared to fast injections at 48 hours follow-up (mean bruising size 
18.76 ± 9.32 mm2 with the slow injection and 109.2 ± 468.66 mm2 with the fast 
injection, P=0.033) and 72 hours follow-up (mean bruising size 21.72 ± 76.16 
mm2 with the slow injection and 110.12 ± 472.86 mm2 with the fast injection,  
P=0.025). The study reported significantly lower pain intensity for slow versus 
fast injection.  
Avsar & Kasikci (2013) conducted a study to determine and compare the 
effects of four different injection techniques on pain and bruising associated with 
subcutaneous heparin. The study used a quasi-experimental design. The four 
different injection techniques are application of subcutaneous heparin without 
aspiration, using airlock technique without aspiration, with aspiration and without 
airlock technique, without aspiration and with airlock technique and two minute 
cold application. The research involved ninety-five patients. Each subject received 
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four injections by the same investigator using four different techniques. Site 
bruising was measured at forty-eight and seventy-two hours after each injection. 
The bruising size was measured using milimetric transparent polyethylene wrap 
and the verbal pain scale. There was significant difference in the size of bruises 
and pain perception in each technique among the subjects. Results of the study 
show that use of air lock technique without aspiration and two-minute cold 
application to the area of injection reduces bruising and pain. 
            John (2013) conducted a study on the effect of time duration in injecting 
subcutaneous heparin on pain and bruising among patients receiving low 
molecular weight heparin injections. It was a quantitative true experimental-cross 
over design among 179 patients receiving subcutaneous low molecular weight 
heparin. In first group the staff nurses administered the first injection using 
standard time duration; the time was noted by the investigator. The second 
injection was given slowly over 30 seconds by the investigator. The pain was 
measured by using VAS and bruise by using transparency scale. In second group, 
first injection given by the investigator and the second injection given by the staff 
nurses. The result shows that of administering injection over 30 seconds reduces 
pain and bruising.  
 Palesa & Aidone (2012) conducted a study on the occurrence and extent of 
bruise according to duration of administration of subcutaneous low molecular 
weight heparin. The results showed that 87 bruises were observed out of 300 
injections.  
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 Neurol., et al (2012) conducted a study on the low-molecular-weight 
heparin and early neurologic deterioration in acute stroke caused by large artery 
occlusive disease (LAOD). Post analysis of controlled trial design was used. 
Among 603 patients recruited, 353 patients (180 treated with LMWH, 173 with 
aspirin) had acute ischemic stroke and LAOD. Patients were randomly assigned to 
receive either subcutaneous LMWH or oral aspirin within 48 hours after stroke 
onset for 10 days, and then all received aspirin once daily for 6 months. For 
patients with acute ischemic stroke and LAOD, treatment with LMWH within  
48 hours of stroke may reduce early neurologic deterioration (END) during the 
first 10 days, mainly by preventing stroke progression. Early neurologic 
deterioration within the first 10 days occurred in 6.7% of LMWH allocated 
patients (12 of 180 patients) compared with 13.9% of aspirin-allocated patients 
(24 of 173). Low molecular-weight heparin was significantly associated with the 
reduction of early neurologic deterioration (absolute risk reduction, 7.2%; 0.44; 
95% CI, 0.21-0.92). When individual components of early neurologic 
deterioration were examined, LMWH was significantly associated with a lower 
frequency of stroke progression within the first 10 days compared with aspirin  
(5.0% [9 of 180] vs 12.7% [22 of 173]; or, 0.36; 95%CI, 0.16-0.81). Early 
neurologic deterioration was significantly associated with 6-month disability with 
both LMWH (12.75; 95% CI, 3.27-49.79 on Barthel Index and, 18.15; 95% CI, 
2.09-157.93 on modified Rankin Scale) and aspirin (6.09; 95% CI, 2.44-15.20 on 
Barthel Index and, 7.50; 95% CI, 2.08- 27.04 on modified Rankin Scale) groups. 
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 Zeraatkari., et al (2011) conducted a study to compare the effect of 
subcutaneous heparin injection on thigh, arm and abdomen. This semi 
experimental complete crossover study was performed on 58 patients who 
received subcutaneous heparin injection, in randomly ordered sites (abdomen, 
arm, and thigh) with a 12 hours interval. The pain intensity was estimated 
immediately after injection using visual analog scale (VAS). Bruise size was 
observed and measured 24, 48 and 72 hours after injection. Statistical analysis was 
performed using ANOVA. Pain intensity was significantly decreased from arm to 
thigh and then to abdomen. According to the results of this study, abdomen area 
may be considered as the preferred site for subcutaneous heparin injection because 
of less pain intensity. 
            Jamula., et al (2009) conducted a study on comparison of pain and 
ecchymosis with low-molecular-weight heparin (LMWH) vs. unfractionated 
heparin (UFH) in patients requiring bridging anticoagulation after warfarin. This 
research randomized 24 patients to receive subcutaneous LMWH or UFH twice-
daily during the perioperative period. Injection associated pain was recorded using 
a visual analogue scale and area of ecchymosis was measured by digital 
photography of the injection site on the day of the procedure. The results  
shows that the area of ecchymosis was 2-fold higher with UFH than LMWH  
(19.4 cm2 vs. 8.98 cm2; P=0.33) and pain was similar with both treatments  
(115 mm vs. 171 mm; P=0.25). 
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 Akpinar & Calebioglu (2008) conducted a study to compare the effects of 
three different injection durations on bruising associated with subcutaneous 
heparin. The study used a quasi-experimental design. The research involved  
36 chronic obstructive pulmonary disease (COPD) patients. Each subject received 
three injections by the same investigator using three different techniques. Site 
bruising was measured at 48 hours after each injection. The bruising size was 
measured using a plastic ruler. Descriptive statistics, Wilcoxon signed-rank and 
McNemar chi-square tests were used to evaluate the data. The level of 
significance was determined at P<0.05. The 30 seconds injection duration and 
waiting 10 seconds before withdrawing the needle resulted in significantly smaller 
and less bruises than 10 seconds injection duration. The 30 seconds duration or 
waiting 10 seconds before withdrawing the needle should be used for 
subcutaneous heparin injections in clinical practice.  
            Zaybak & Khorshid (2008) conducted a study on the effect of the duration 
of subcutaneous heparin injection on bruising and pain. This study was quasi-
experimental research. The sample for the study consisted of 50 patients. Heparin 
was injected over 10 seconds on the right abdominal site and over 30 seconds on 
the left abdominal site. Injections areas were assessed for the presence of bruising 
at 48 and 72 hours after each injection. Bruising was measured using transparent 
millimetric measuring paper. The visual analog scale (VAS) was used to measure 
pain intensity and a stop-watch was used to time the pain period. Data were 
analyzed using chi-square test, Mann-Whitney U, Wilcoxon signed ranks tests and 
correlation. The percentage of bruising occurrence was 64% with the injection of 
10 seconds duration and 42% in the 30-second injection. It was determined that 
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the size of the bruising was smaller in the 30-second injection. Pain intensity and 
pain period were statistically significantly lower for the 30-second injection than 
for the 10-second injection. It was determined that injection duration had an effect 
on bruising and pain following the subcutaneous administration of heparin. 
 Nair., et al (2008) conducted a study on effect of time taken in injecting 
subcutaneous heparin injection with reference to site pain and bruising. In the 
present study a two group design was used among cardiac patients undergoing 
heparin therapy. In the control group, the time taken for administering 
subcutaneous heparin in the routine practice was noted, while in the experimental 
group 30 seconds injection technique was utilized. All other steps of injection 
administration were kept same in both the groups. A total of 100 injection sites 
were taken in each group and assessed for pain at 0, 24, 48, 60 hours and for 
bruise at 24, 48 and 60 hours. It was observed that, in the control group, nurses 
gave the injections over 4-10 seconds. Results show that there was no significant 
difference in the perceived site pain in both groups. However, when mean bruise 
sizes were compared, it was observed that they were significantly less in the 
subjects receiving subcutaneous heparin injection through the 30 second injection 
duration technique (p<0.05).  
 Neshat., et al (2005) conducted a study to determine the relation between 
duration of injection of subcutaneous heparin and extent of local skin 
discoloration. The research design was quasi-experimental design. Consecutive 
sampling technique was used to select 167 patients. Data collection was done by 
using a researcher-made check-list consisting of section of demographic 
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characteristics and a section to record the extent of discoloration at 48 and            
60 hours after injection. Data analysis was done by distributional index and 
parametric (paired-t test) and Bi-parametric (Mann Whitney-U and Kruskal 
Wallis). Extent of local skin discoloration was less in 30-second injection 
technique, so that the mean size at 48 and 60 hours after 10-second injection 
techniques (82.85, 214.3; 77.96, 206 respectively) was more than the mean size at 
48 and 60 hours after 30-second injection technique (40.53, 148.11; 44.41, 175.51 
respectively). There was a significant relationship between sex and size of 
discoloration (p<0.001), so that mean size in females in the 10-second and  
30-second injection techniques at 48 and 60 hours after injection was more than 
that in males. Administering subcutaneous heparin injection over longer duration, 
especially in females reduces injection site discoloration. 
 Chan (2001) conducted a study on the effects of injection duration on site-
pain intensity and bruising associated with subcutaneous heparin. This research 
study determines the effects of injection duration (10 and 30-seconds) on site-pain 
intensity and bruising. The research used a quasi-experimental research design. 
The research involved 34 stroke patients receiving low-molecular weight heparin. 
For each subject, one of the two injection techniques was used as the first 
injection and 12 hours later the other injection technique was used. Subjects rated 
the level of perceived site-pain intensity using the vertical visual analogue scale 
(VAS). Injection-site bruising was measured at 48 and 60 hours after each 
injection. Digital planimetry was used to measure the surface-area of  
bruise tracings. The final data set for analysis consisted of 68 VAS pain scores 
and 136 bruise sizes. Wilcoxon Signed-Rank tests were used to determine the 
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effects caused by injection duration on site-pain and bruise size. The level of 
significance was determined at P<0.05. Results indicated that the 30-second 
duration injection technique resulted in significantly less intense site-pain and 
fewer and smaller bruises. The result shows that administering a subcutaneous 
heparin injection over longer duration reduces injection site-pain and bruising.  
            Klingman (2000) conducted a study on effects of changing needles prior to 
administering heparin subcutaneously would cause less ecchymosis at the 
injection site. A quantitative study, a measurement of ecchymosis was obtained  
48 hours after injection of heparin on the right side of the abdomen, where the 
needle was changed before injection. A second measurement was obtained  
48 hours after injection on the left side of the abdomen, where the needle was not 
changed before injection. A comparison was then made of the two measurements. 
The student µW¶ test for related samples was used, and the significance was set at  
P<0.05. The mean size of the ecchymosis for the sites where the needle was 
changed was 5.16 mm, and the mean size of the ecchymosis for the sites where 
the needle was not changed was 5.44 mm (P=0.87). Changing the needle before 
the administration of subcutaneous heparin did not decrease the size of 
ecchymosis as compared with the size of ecchymosis when the investigator did 
not change the needle.  
            Kalafut., et al (2000) conducted a study on anticoagulation with 
intravenous unfractionated heparin (IVUH) while awaiting therapeutic oral 
anticoagulant levels is a common practice in patients with acute and sub-acute 
cerebral ischemia. A promising alternative strategy is to use bridging 
subcutaneous low molecular weight heparin (LMWH), which may have a 
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favorable risk-benefit profile compared with IVUH and may permit earlier 
discharge with completion of transition to warfarin therapy as an outpatient. A 
LMWH, enoxaparin 1 mg/kg BID, was used as bridging anticoagulation therapy 
in 24 consecutive patients admitted to a university stroke center in which the 
treatment plan included transition from acute to chronic anticoagulation. Fewer 
patients in the LMWH bridging therapy group experienced neurological 
worsening than in the IVUH bridging therapy group (2/24 versus 8/24; P-0.033). 
Fewer total adverse events were noted in the LMWH group than in the IVUH 
cohort (3 versus 20; P-0. 002). Fifteen of the 24 LMWH patients (62.5%) were 
discharged while still receiving LMWH and completed transition to warfarin as 
outpatients, receiving an average of 3.6 days of outpatient transitional therapy. In 
this pilot cohort with sub-acute cerebral ischemia, bridging LMWH appeared to be 
safer than bridging IVUH and was associated with reduced hospital stay and 
reduced total cost of care. 
            Wooldridge & Jackson (1998) conducted a study on evaluation of bruises 
and areas of induration after two techniques of subcutaneous heparin injection. 
Variables studied included syringe size, change of needles after drawing 
medication into the syringe, use of an air bubble, and type of sponge (dry or 
alcohol) applied to the site after injection. The sample included 50 medical-
surgical patients aged 23 to 88 years. Each subject received two injections by the 
same investigator using two different techniques. Sites were inspected and bruises 
and induration measured 52 hours after each injection. To compare the size of 
bruises and indurations, the data were analyzed by the Mann-Whitney  
U-Wilcoxon rank sum test, which showed a 0.003 level of significance for bruises 
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and a 0.02 level of significance for induration. To compare the number of subjects 
in whom bruises and indurations developed, the data were analyzed by the chi-
square test, which showed a 0.0458 level of significance for induration but only a 
0.1371 level of significance for bruising. 
 Hadley., et al (1996) conducted a study on effect of syringe size on 
bruising following subcutaneous injection among 29 subjects. They received  
5000 units of subcutaneous heparin twice a day. Subjects received their regularly 
scheduled subcutaneous heparin injections with a 3-ml or a 1-ml syringe in a 
randomized sequence using a standardized procedure. Injection sites were 
assessed for bruises and indurations at 24, 48, and 72 hours after injection. The 
incidence of injection site bruising with 1ml and 3ml syringes was 79% and 69%, 
respectively. The use of a 3ml vs 1ml syringe resulted in significantly smaller 
bruises at 48 and 72 hours after injection. Indurations at the injection site occurred 
in three patients.   
          Gowan & Wood (1990) conducted a study to evaluate techniques used for 
administering heparin subcutaneously on bruising at the injection site. This 
experimental study tested the effects of four different subcutaneous injection 
techniques on bruising at the injection site. The independent variables of 
aspiration of the syringe prior to injecting heparin and pressure on the site 
following injection, and the dependent variable of size of bruising were studied. 
After the first injection, fewer subjects who received pressure following the 
injection had bruising. However analysis of subsequent injections shows 
aspiration of the syringe had little effect on bruising. 
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2.2       Literature Related to Effect of Cold Application 
            Sendir., et al (2015) conducted a study to compare the effects of the 
injection duration (30 seconds) and local dry cold application (5 minutes before 
and after injection) on pain intensity and bruising at the injection site in 
subcutaneous heparin injections. This was a randomized controlled, prospective, 
experimental study. The sample consisted of 60 patients receiving subcutaneous 
injections of heparin once a day. A computerized randomization program was 
used to allocate the patients to 3 experimental groups: group A (30-second 
injection duration), group B (30-second injection duration and 5-minute dry cold 
application applied locally), and group C (injection administered for 10 seconds 
and no dry cold application applied locally). This study observed statistically 
significant differences in pain intensity and bruising occurrence and formation 
measured over time among groups A, B C. In the present study, the incidence of 
bruising was high (70%), and the size of the bruises peaked at 48 and 60 hours, 
respectively, after the 10-second subcutaneous injections. bruising incidence was 
determined high level at 48 hours after the rapid subcutaneous application. This 
study concluded that subcutaneous injection duration of 30 seconds and 5-minutes 
local dry cold application (before and after injection) can be effective in 
decreasing the intensity of pain and in reducing the occurrence of bruising. 
            Sheikh (2010) conducted a study on the effectiveness of ice cube 
application in reducing pain before giving intra muscular injection among adults.  
In this study pre-experimental design (one group pre-test, posttest) was used. 
Independent variable was ice cube application and the dependent variable was 
pain during intramuscular injection. 60 patients were selected using purposive 
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sampling technique. Pre-test score of pain level was obtained by using numerical 
pain scale. And post test score of pain was obtained following the application of 
ice cube for 10 minutes. The result shows the ice cube application was effective in 
reducing pain before giving intra muscular injection among adults.   
           Sunny (2010) conducted a study on the effectiveness of local cold 
application on pain response during intravenous procedures among children. In 
this study posttest only control group design was used. The sample for the study 
comprised of 60 children with age group of 3-12 years, 30 children for 
experimental group and 30 children for control group who are undergoing 
intravenous procedures. After administering the local cold application pain was 
assessed by using Eastern Ontario Pain Scale. The result shows the local cold 
application was effective on pain response during intravenous procedures.  
            George (2008) conducted a study on the effectiveness of ice cube as an 
anesthetic pretreatment for intradermal injection among adults. The research 
design was the quasi experimental posttest only control group design. The 
sampling procedure was non probability purposive sampling technique with 
random assignment to experimental and control group. The sample size was  
40 adults receiving intradermal injection. Twenty subjects were in the control 
group and 20 subjects were in the experimental group. Ice cube was applied at the 
site of injection for 3 minutes prior to intradermal injection for experimental group 
and ice cube was not applied for control group. The intensity of pain during the 
procedure in both the groups was assessed using visual analogue scale. The result 
shows that there is a significant reduction in pain during intra dermal injection 
among adults.  
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 Pushpa., et al (2008) conducted a study on prevention and reduction of 
pain, bruise and hematoma by moist ice pack application on the subcutaneous 
heparin injection among 200 subjects. Subjects in the experimental group received 
moist ice pack application for 5 minutes twice daily for 3 days .The pain was 
assessed by using visual analogue scale at 12 hours, 48 hours and 72 hours after 
the first subcutaneous heparin injection. Result showed that 66% of subjects in the 
experimental group had no pain at 72 hours, however only 7% in control group 
had no pain at 72 hours. They concluded that the application of moist ice pack can 
be effective in preventing and reducing pain, bruise and haematoma at 
subcutaneous heparin injection site. 
 Hasanpour., et al (2006) conducted a study on the effects of two non-
pharmacologic pain management methods for intramuscular injection pain.  
90 children with ages from 5 to 12 years who had penicillin injection 
intramuscularly were studied. The samples were divided into three groups: the 
first group received local cold therapy, the second group received distraction and 
the third group (the control group) received routine care. Oucher scale was used to 
measure pain intensity. The average pain score in local cold therapy was 26.3, in 
distraction were 34.3 and in control group were 83.3 respectively, which show 
that local cold was effective in reducing intramuscular injection related pain. The 
results measured as pain intensity was significantly higher in the control group 
than the experimental groups.  
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 Ebner (1996) conducted a study to determine whether cold therapy 
decreased the perceived pain associated with intramuscular injection. A quasi 
experimental study was used. 40 patients with age 10 to 80 years was randomly 
assigned to control and experimental group. The experimental group had an ice 
pack was applied on the injection site 15 minutes prior to injection and control 
group with normal routine care. Patients who receive cold therapy showed 
significant reduction in intra muscular injection pain. 
 Ross & Soltes (1995) conducted a study to determine the effect of ice 
application to the site of subcutaneous heparin injection on pain, incidence and 
size of haematoma formation. The study used a quasi-experimental design with 
the subjects as their own control. A convenience sample of 70 subjects was each 
given two injections of subcutaneous heparin, 12 hours apart. Ice was applied pre- 
and post-injection to one of the sites. Immediately following each injection, the 
subjects were asked to rate the level of perceived discomfort at the time of the 
injection using a visual analogue scale. Forty-eight hours post-injection, the 
researcher inspected the injection sites for the presence of haematoma. Results 
showed that when ice was applied the subject's perception of pain was 
significantly less. 
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2.3    Literature Related to Effect of Dry Cold Application on Pain 
Perception and Ecchymosis 
            Batra (2014) conducted a study on the application of ice cube prior to 
subcutaneous injection of heparin on pain perception and ecchymosis of patients 
with cardiovascular problems. It was a quasi-experimental study posttest only 
control group design among 30 experimental group and 30 control group patients. 
The independent variable for the study was ice cube application for 3 min and the 
dependent variables were pain perception and ecchymosis. Subjects were asked to 
rate pain immediately after the needle was withdrawn and ecchymosis was 
observed 48 hours after the day of injection. &DOFXODWHGµW¶YDOXHZDVIRUSDLQ
perception and 4.4 for ecchymosis was statistically significant at 0.05 level. Ice 
cube application prior to injection is effective for pain perception and ecchymosis. 
            Melba & Priyalatha (2009) conducted a study on the effectiveness of dry 
cold application on the occurrence of bruising and pain at the subcutaneous 
injection site of LMWH. It was an experimental study among 30 patients in the 
interventional group and 30 patients in the control group with cardiovascular 
problems. Dry cold was applied for duration of 15 minutes to the interventional 
group for three consecutive days. The intensity of pain was reassessed  
after 1 hour, 4 hours and 8 hours of injection and area of bruising was reassessed 
after 8 hours. This study finding indicates that dry cold application was effective 
in reducing the intensity of pain and bruising among interventional group after dry 
cold application (pain score 0-1) when compared to the control group (pain score 
1-4). The findings at 1 hour and 24 hours (t=9.856 and 2.693 respectively,  
p<0.05), Fishers Exact 4.104, p< 0.05 were statistically significant. 
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            Varghese., et al (2006) conducted a study on effect of moist ice pack 
application on prevention and reduction of pain, bruise and hematoma on the site 
of subcutaneous heparin injection. The sample size consisted of 100 each in the 
experimental and control group respectively. The moist ice pack application was 
performed for 5 minutes at the subcutaneous heparin injection site twice daily for 
three days in the experimental group. Assessment of pain, bruise and hematoma 
were carried out at 12, 48 and 72 hours in both the groups. Results were 
statistically significant in favour of the use of moist ice pack while comparing the 
pain and bruise at subcutaneous injection site between experimental and control 
group at 12, 48 and 72 hours  (p<0.05 and p< 0.01). 
            Kuzu & Ucar (2001) conducted a study on the effect of local dry cold 
application on the occurrence of bruising, haematoma and pain at the injection site 
of subcutaneous low molecular weight heparin. The research involved 63 patients 
who had received 40 mg enoxaparin and who were divided into four treatment 
groups. In the first group, cold was not applied. Cold was applied to the injection 
site for 5 minutes before the injection in the second group, and for 5 minutes after 
the injection in the third group. In the fourth group, cold was applied to the 
injection site for 5 minutes pre and post injection. Following each injection, the 
patients pain intensity and induration were measured, and the presence of bruise 
and haematoma were measured at 48 and 72 hours after the injection. Results 
showed that the subjects pain perception was significantly less with ice 
application. 
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METHODOLOGY 
 
 This chapter deals with the description of research approach, research design, 
research setting, sampling technique, criteria for sample selection, variables of the 
study, tools  for data collection, pilot study, procedure for data collection and 
techniques of data analysis and interpretation. 
3.1 Research Approach  
 Quantitative research approach involves the generation of data in quantitative 
form (Polit & Beck, 2012). The present study was aimed to assess the effect of dry 
cold application on pain perception and ecchymosis among patients receiving low 
molecular weight heparin. In view of the nature of problem and to accomplish the 
objectives, quantitative research approach was adopted for the study. The changes in 
the dependent variables are measured after manipulating the independent variable.  
3.2       Research Design 
            The research design used for the present study was true experimental posttest 
only control group design. In this study the samples were selected using total 
enumerative sampling technique and were randomly assigned to experimental and 
control group (Sharma, 2011). The dry cold application was given to the experimental 
group for 3 minutes prior to administration of injection LMWH. Injection LMWH 
was administered to the experimental and control group. Posttest was done to the 
experimental and control group to examine the effect of dry cold application on pain 
perception and ecchymosis among patients receiving low molecular weight heparin. 
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3.3        Setting         
             The study was conducted in the general (neuro ward) and special wards of  
Sri Ramakrishna Hospital, Coimbatore. It is a 700 bedded super specialty hospital 
under the SNR Sons Charitable Trust. In this approximately 318 patients receive 
Injection LMWH per year and 27 patients per month.  
3.4        Population  
             Target population for the present study was the patients who are receiving 
low molecular weight heparin. The accessible population includes the patients who 
are receiving low molecular weight heparin in Sri Ramakrishna Hospital, Coimbatore 
District during the study period. 
3.5        Sampling  
             Total Enumerative Sampling technique was used to select the samples. 
Totally 25 patients were receiving injection low molecular weight heparin during the 
period of data collection. All the 25 patients who met the sampling criteria were 
randomly assigned to experimental group (n=13) and control group (n=12) using 
lottery method. 
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Figure 3.1 
Schematic Representation of Research Process 
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x Assessment of pain perception immediately after withdrawing the 
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3.6  Criteria for Sample Selection 
3.6.1    Inclusion Criteria 
x Patients who are receiving LMWH (Low Molecular Weight Heparin). 
x Patients of all age groups.  
3.6.2 Exclusion Criteria 
x Patients who are unconscious. 
x Patients with haemorrhagic vascular cerebral stroke. 
x Patients with impaired renal function. 
x Patients with uncontrolled arterial hypertension. 
3.7       Variables of the Study  
The independent variable in the present study was dry cold application. The 
dependent variables in the present study were pain perception and ecchymosis among 
patients receiving low molecular weight heparin. 
Figure 3.2 
Diagrammatic Representation of Variables 
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Dependent 
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3.8 Tools of Data Collection 
            The demographic profile, clinical profile, numerical rating scale and 
transparent ruler scale were framed based on the expert opinion and the supportive 
literatures. The following tools were used for the data collection to assess the effect of 
dry cold application on pain perception and ecchymosis among patients receiving low 
molecular weight heparin and it consists of four sections.     
3.8.1 Questionnaire on Demographic profile  
3.8.2 Questionnaire on Clinical profile 
3.8.3 Numerical pain rating scale 
3.8.4 Transparent ruler scale  
3.8.1    Questionnaire on Demographic Profile  
 Demographic profile consists of sample number, age, gender, educational 
status, marital status, religion, occupation. 
3.8.2  Questionnaire on Clinical Profile 
            Clinical profile consists of diagnosis, name of the injection and dose, 
frequency of Inj. LMWH, and presence of any other illness.  
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3.8.3    Numerical Pain Rating Scale to Assess Pain Perception 
     This standardized Numerical Pain Rating Scale given by Mc Caffery (1989) 
was used to assess the level of pain perception among patients receiving low 
molecular weight heparin. The pain perception was assessed in the right and left 
upper outer arm, right and left thigh. The scale has five categories such as No pain, 
mild pain, moderate pain, severe pain and unbearable pain. The total score is 10.  
 
The score is interpreted as: 
 
 
 
x 0: No pain  
x 1-3: Mild pain 
x 4-6: Moderate pain 
x 7-8: Severe pain 
x 9-10: Unbearable pain        
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3.8.4 Transparent Ruler Scale to Assess Ecchymosis 
The size of the ecchymosis was assessed in the right and left upper outer arm, 
right and left thigh by using transparent ruler scale.  The length and width of the 
ecchymosis was measured and the total surface area calculated in cm2.   
Area = Length × Width (l × w) 
 
 
 
 
 
 
3.9 Dry Cold Application Procedure 
After the selection of samples the demographic and clinical data was 
collected. The patient was placed in a comfortable position. All the articles were 
assembled near the patient. The ice cap was filled with ice cubes. Dry cold 
application was given for 3 minutes on the LMWH injection site for the experimental 
group. Injection LMWH was administered subcutaneously to the experimental group 
and control group. Pain was assessed immediately after withdrawing the needle,  
4 hours and 8 hours by using numerical pain rating scale. Ecchymosis was assessed 
48 hours and 72 hours after the day of injection by using transparent ruler scale. 
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3.10     Validity and Reliability of the Tool 
            Validity refers whether an instrument accurately measures what it is supposed 
to measure. The prepared tool was validated by seven subject experts that included 
six nursing faculty and one medical expert. The experts were requested to give their 
opinion and suggestions regarding relevance, appropriateness, accuracy and degree of 
agreement in each item of the tool. Suggestions and recommendations given by the 
experts were accepted and necessary corrections were done. The content validity of 
HDFK LWHPRI WKH WRROZDV FRPSXWHG XVLQJ/\QQ¶V LWHPZLVH FRQWHQW YDOLGLW\ LQGH[  
(I- CVI) and the values were found to be greater than 0.83 and which indicates the 
content validity based on I-CVI interpretation for six or more experts. So the tool was 
found to have high content validity. Test-retest reliability value of numerical pain 
rating scale is r = 0.76 to r = 0.89. 
3.11  Ethical Committee Clearance 
 The proposed study and tool were presented to the institution ethical 
committee and the same was approved by the committee. 
3.12     Pilot Study 
            Pilot study was conducted to find out feasibility and practicality of the study. 
Duration of the pilot study was ten days. The pilot study was conducted in general 
and special wards of Sri Ramakrishna hospital, Coimbatore. True experimental 
posttest only control group design was adopted. Total enumerative sampling 
technique was used to select the samples and they were randomly assigned to 
experimental group (n=4) and control group (n=4).   
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            Dry cold application was given for 3 minutes on the LMWH injection site to 
the experimental group. Injection LMWH was administered subcutaneously to the 
experimental and control group by the researcher. Posttest was done to assess the pain 
perception immediately after withdrawing needle, 4 hours, and 8 hours by using 
numerical pain rating scale and ecchymosis was assessed 48 hours and 72 hours after 
the day of injection by using transparent ruler scale. Descriptive and inferential 
statistical methods were used for data analysis. Pain perception was analyzed 
immediately after withdrawing the needle, 4 hours and 8 hours (t = 4.899, 2.877 and 
3.472 respectively, d =6, p<0.05).  Ecchymosis was analyzed after 48 hours and                 
72 hours (t=4.931 and 3.48 respectively, df=6, p<0.05). The result of pilot study 
revealed that dry cold application was effective in reducing pain perception and 
ecchymosis among patients receiving low molecular weight heparin. After pilot study 
the researcher was advised to do data analysis for each LMWH injection site 
separately in the main study because the pain perception and ecchymosis is different 
in each LMWH injection site and the same was adopted in the main study.  
3.13 Procedure for Data Collection 
   The main study was conducted over a period of one month from 23.06.2015 to 
19.07.2015 at Sri Ramakrishna Hospital, Coimbatore. Total enumerative sampling 
technique was used to select the samples. The 25 patients who met the sampling 
criteria were randomly assigned to experimental (n=13) and the control group (n=12). 
The demographic and clinical data was collected. Dry cold application was given  
for 3 minutes on LMWH injection site. Injection LMWH was administered 
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subcutaneously to the experimental and control group by the researcher. Dry cold 
application was given for 5 consecutive days. Posttest was done for both the 
experimental and control group to assess the pain perception immediately after 
withdrawing needle, 4 hours, and 8 hours by using numerical pain rating scale and 
ecchymosis was assessed 48 hours and 72 hours after the day of injection by using 
transparent ruler scale. 
3.14 Techniques of Data Analysis and Interpretation  
            Descriptive and inferential statistical techniques were used for data analysis. 
Descriptive statistics was applied for the analysis of demographic variables and 
clinical variables. The frequency tables were formulated for all significant 
information. Mean, Mean difference, Standard Deviation and UQSDLUHG µW¶ WHVWZDV
used to find out the significance of pain perception and ecchymosis among patients 
receiving  LMWH. 
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3.13.1 8QSDLUHGµW¶ test 
       Unpaired µW¶ test was used to analyze the effect of dry cold application on pain 
perception and ecchymosis among patients receiving LMWH in control and 
experimental groups.  
t = 
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Where,  
SD = standard deviation  
SE = standard error 
x  = mean of the Experimental group (post test score) 
y  = mean of the Control group (post test score)  
n1 = number of samples in Experimental group 
n2     = number of samples in Control group  
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DATA ANALYSIS AND INTERPRETATION 
 
 This Chapter deals with the analysis and interpretation of data collected 
from 25 patients receiving low molecular weight heparin. The aim of the study 
was to determine the effect of dry cold application on pain perception and 
ecchymosis among patients receiving low molecular weight heparin at selected 
hospital, Coimbatore. 25 patients were selected using total enumerative sampling 
technique. The total samples were randomly assigned to the experimental group 
(n=13) and the control group (n=12). Dry cold application was given for  
3 minutes on the LMWH injection site for the experimental group. Injection 
LMWH was administered subcutaneously to the experimental group and control 
group. Pain perception was assessed by numerical pain rating scale and 
ecchymosis was assessed by transparent ruler scale. Descriptive and inferential 
statistical methods were employed to organize and analyze the data. 
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ORGANIZATION OF FINDINGS 
Section I 
 Demographic variables of patients receiving low molecular weight heparin 
in experimental and control group. 
Section II 
 Clinical variables of patients receiving low molecular weight heparin in 
experimental and control group. 
Section III 
 Assessment on the level of pain perception after dry cold application 
among patients receiving low molecular weight heparin in experimental and 
control group.  
Section IV 
 Assessment on the size of ecchymosis after dry cold application among 
patients receiving low molecular weight heparin in experimental and control 
group.  
Section V 
 Effect of dry cold application on pain perception among patients receiving 
low molecular weight heparin in the experimental and control group. 
Section VI 
Effect of dry cold application on ecchymosis among patients receiving low 
molecular weight heparin in the experimental and control group. 
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Section I 
4.1  Demographic Variables of Patients receiving Low Molecular Weight 
Heparin 
 This section includes the demographic variables collected from the 
patients receiving low molecular weight heparin. The demographic variables 
collected were age, gender, educational status, marital status, religion, and 
occupation. 
Table 4.1.1 
Age of Patients receiving LMWH  
(n=25) 
S. No Age (in years) 
Experimental group 
(n=13) 
Control group 
(n=12) 
Frequency 
Percentage 
(%) 
Frequency 
Percentage 
(%) 
1. Below 30    1 7.69 1 8.33 
2. 31-40  - - 2 16.67 
3. 41-50 3 23.08 1 8.33 
4. Above 51  9 69.23 8 66.67 
 
 The above table 4.1.1 depicts the age of patients receiving LMWH and the 
result shows that in the experimental group 9 (69.23%) patients were above  
51 years, 3 (23.08%) patients were between the age group of 41 and 50 years,  
1 (7.69%) patient was below 30 years. In the control group 8 (66.67%) patients 
were above 51 years, 2 (16.67%) patients were between the age group of 31 and  
40 years, 1 (8.33%) patient was below 30 years and 41-50 years respectively. 
(Figure 4.1.1) 
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Table 4.1.2 
Gender of Patients receiving LMWH  
(n=25) 
S. No Gender 
Experimental group 
(n=13) 
Control group 
(n=12) 
Frequency Percentage (%) Frequency 
Percentage 
(%) 
1. Male 10 76.92 6 50 
2. Female 3 23.08 6 50 
 
           The above table 4.1.2 depicts the gender of patients receiving LMWH and 
the result shows that in the experimental group 10 (76.92%) of patients were 
males, 3 (23.08%) of patients were females, and in the control group 6 (50%) of 
the patients were males and females respectively. (Figure 4.1.2) 
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Figure 4.1.1 
Age of Patients receiving LMWH 
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Table 4.1.3 
Educational Status of Patients receiving LMWH  
(n=25) 
S. No 
Educational 
status 
Experimental group 
(n=13) 
Control group 
(n=12) 
Frequency Percentage (%) Frequency 
Percentage 
(%) 
1. Illiterate 1 7.69 1 8.33 
2. Primary School 3 23.08 1 8.33 
3. High School 6 46.15 5 41.67 
4. Higher Secondary 3 23.08 3 25 
5. Graduate - - 2 16.67 
 
            The above table 4.1.3 depicts the educational status of patients receiving 
LMWH. The result shows that in the experimental group 3 (23.08%) patients had 
higher secondary education, 6 (46.15%) patients had high school education,  
3 (23.08%) patients had primary school education, and 1 (7.69%) patient was 
illiterate. In the control group 2 (16.67%) patients were graduates, 3 (25%) 
patients had higher secondary education, 5 (41.67%) patients had high school 
education, 1 (8.33%) patient had primary school education, and 1 (8.33%) patient 
was illiterate. (Figure 4.1.3) 
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Table 4.1.4 
Marital Status of Patients receiving LMWH  
(n=25) 
S. No Marital status 
Experimental group 
(n=13) 
Control group 
(n=12) 
Frequency Percentage (%) Frequency 
Percentage 
(%) 
1. Single 1 7.69 1 8.33 
2. Married 11 84.62 9 75 
3. Widow 1 7.69 2 16.67 
 
            The above table 4.1.4 depicts the marital status of patients receiving 
LMWH reveals that in the experimental group 11 (84.62%) patients were married, 
1 (7.69%) patient was single and 1 (7.69%) patient was widow. In the control 
group 9 (75%) patients were married, 2 (16.67%) patients were widows and  
1 (8.33%) patient was single. (Figure 4.1.4) 
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Figure 4.1.3 
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Table 4.1.5 
Religion of Patients receiving LMWH  
LMWH BASED O (n=25) 
S. No Religion 
Experimental group 
(n=13) 
Control group 
(n=12) 
Frequency Percentage (%) Frequency 
Percentage 
(%) 
1. Hindu  13 100 10 83.33 
2. Muslim  - - 2 16.67 
 
            The above table 4.1.5 depicts the religion of patients receiving LMWH 
shows that majority of patients belonged to Hindu religion, 13 (100%) in 
experimental group and 10 (83.33%) in control group. (Figure 4.1.5) 
Table 4.1.6 
Occupation of Patients receiving LMWH 
(n=25) 
S. 
No Occupation 
Experimental group 
(n=13) 
Control group 
(n=12) 
Frequency Percentage (%) Frequency 
Percentage 
(%) 
1. Employed  9 69.23 6 50 
2. Unemployed 4 30.77 6 50 
 
           The above table 4.1.6 depicts that the occupation of patients receiving 
LMWH shows that in the experimental group 9 (69.23%) patients were employed, 
4 (30.77%) patients were unemployed and in the control group 6 (50%) patients 
were employed and unemployed respectively. (Figure 4.1.6) 
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Figure 4.1.5 
 
 
 
Figure 4.1.6 
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Section II 
4.2 Clinical Variables of Patients receiving Low Molecular Weight 
Heparin  
This section presents the clinical variables collected from the patients 
receiving low molecular weight heparin. The clinical variables are diagnosis of the 
patient, name of the injection and dose, frequency of injection and presence of any 
other illness. 
Table 4.2.1 
Diagnosis of Patients receiving LMWH 
D ON RE (n=25) 
S. 
No Diagnosis 
Experimental group 
(n=13) 
Control group  
(n=12) 
Frequency Percentage (%) Frequency 
Percentage 
(%) 
1. Cerebro Vascular 
Accident 
10 76.92 8 66.67 
2. Deep Vein 
Thrombosis 
1 7.69 1 8.33 
3. Cerebro Vascular 
Thrombosis  
- - 2 16.67 
4. Others  2 15.39 1 8.33 
  
            The above table 4.2.1 depicts the diagnosis of patients receiving LMWH 
reveals that in the experimental group 10 (76.92%) patients were diagnosed with 
CVA (Cerebro Vascular Accident), 2 (15.39%) patients were diagnosed with other 
diseases such as autoimmune encephalitis, seizure disorder, 1 (7.69%) patient was 
diagnosed with DVT (Deep Vein Thrombosis) and in the control group                          
8 (66.67%) patients were diagnosed with CVA, 2 (16.67%) patients were 
diagnosed with CVT (Cerebro Vascular Thrombosis), 1 (8.33%) patients were 
diagnosed with deep vein thrombosis, 1 (8.33%) patient were diagnosed with 
hepatoma. (Figure 4.2.1) 
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Table 4.2.2 
Name of Injection LMWH received by Patients  
DIS (n=25) 
 
  The above table 4.2.2 depicts that name of injection LMWH received by 
patients shows that in the experimental group 8 (61.53%) patients received                    
Inj. Flothin 40 mg, 2 (15.39%) patients received Inj. Lupenox 40 mg and                    
Inj. Clexane 40 mg  respectively, 1 (7.69%) patient received Inj. Enox  40 mg and 
in the control group 8 (66.67%) patients received Inj. Flothin 40 mg, 2 (16.67%) 
patients received Inj. Enox 40 mg, 1 (8.33%) patient received Inj. Lupenox 40 mg 
and Inj. Clexane 40 mg respectively. (Figure 4.2.2) 
 
 
 
 
 
 
 
 
S. 
No 
Name of the 
injection 
Experimental group 
(n=13) 
Control group 
(n=12) 
Frequency Percentage (%) Frequency 
Percentage 
(%) 
1. Inj. Lupenox 40 mg 2 15.39 1 8.33 
2. Inj. Flothin 40 mg 8 61.53 8 66.67 
3. Inj. Enox 40 mg 1 7.69 2 16.67 
4. Inj. Clexane 40 mg 2 15.39 1 8.33 
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Table 4.2.3ON 
Presence of Any Other Illness among Patients receiving LMWH 
(n=25) 
S. 
No 
Any other 
illness 
Experimental group 
(n=13) 
Control group 
(n=12) 
Frequency Percentage (%) Frequency 
Percentage 
(%) 
1. Present  10 76.92 6 50 
2. Absent  3 23.08 6 50 
           
          The above table 4.2.3 depicts that in the presence of any other illness among 
patients receiving LMWH reveals that in the experimental group 10 (76.92%) 
patients had other illness, 3 (23.08%) patients had no other illness and in the 
control group 6 (50%) patients had other illness, 6 (50%) patients had no other 
illness such as DM (Diabetes Mellitus), SHT (Systemic Hypertension), IHD 
(Ischemic Heart Disease), CHF (Congestive Heart Failure), CRF (Chronic Renal 
Failure), PVD (Peripheral Vascular Disease) etc. (Figure 4.2.3) 
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Figure 4.2.1 
 
 
Figure 4.2.2 
Name of Injection LMWH received by Patients 
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Figure 4.2.3 
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Section III 
4.3   Assessment on the Level of Pain Perception after Dry Cold 
Application among Patients receiving Low Molecular Weight Heparin 
in Experimental Group and Control Group 
            This section deals with the analysis and interpretation assessment on the 
level of pain perception after dry cold application among patients receiving low 
molecular weight heparin.  The pain perception was assessed immediately after 
withdrawing needle, 4 hours, and 8 hours in the right upper outer arm, left upper 
outer arm, right thigh and left thigh by using numerical pain rating scale was 
categorized as no pain, mild pain, moderate pain, severe pain, unbearable pain.   
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Table 4.3.1 
Level of Pain Perception among Patients receiving Low Molecular Weight 
Heparin in Experimental Group and Control Group                                           
(Right Upper Outer Arm) 
(n=25) 
S.
 N
o Pain 
perception 
Right Upper Outer Arm 
Experimental group (n=13) Control group (n=12) 
Immed
iately 
after 
withdr
awing 
needle 
After     
4 Hours 
After    
8 
Hours 
Immedia
tely after 
with-
drawing 
needle 
After      
4 Hours 
After    
8 
Hours 
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(%
)
1. No Pain - - 13 100 13 100 - - 4 33.33 6 50 
2. Mild Pain 13 100 - - - - - - 8 66.67 6 50 
3. Moderate Pain - - - - - - 8 66.67 - - - - 
4. Severe Pain - - - - - - 4 33.33 - - - - 
5. Unbearable Pain - - - - - - - - - - - - 
 
           The above table 4.3.1 depicts the level of pain perception among patients 
receiving low molecular weight heparin in experimental group and control group 
(right upper outer arm), shows that in the experimental group immediately after 
withdrawing needle 13 (100%) patients had mild pain, after 4 hours and 8 hours 
13 (100%) patients had no pain respectively, whereas in the control group 
immediately after withdrawing needle 8 (66.67%) patients had moderate pain and 
4 (33.33%) had severe pain, after 4 hours, 8 (66.67%) patients had mild pain,                
4 (33.33 %) patients had no pain, and after 8 hours 6 (50%) patients had no pain 
and mild pain respectively. (Figure 4.3.1.1 and Figure 4.3.1.2)      
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Figure 4.3.1.1 
 
 
Figure 4.3.1.2 
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Table 4.3.2 
Level of Pain Perception among Patients receiving Low Molecular Weight 
Heparin in Experimental Group and Control Group (Left Upper Outer Arm) 
(n=25) 
S.
 N
o Pain 
perception 
Left Upper Outer Arm 
Experimental group (n=13) Control group (n=12) 
Immedia
tely after 
withdra
wing 
needle 
After    
4 hours 
After    
8 hours 
Immedi
ately 
after 
withdra
wing 
needle 
After      
4 Hours 
After    
8 
Hours 
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1. No Pain - - 13 100 13 100 - - 2 16.67 7 58.33 
2. Mild Pain 12 92.31 - - - - - - 10 83.33 5 41.67 
3. Moderate Pain 1 7.69 - - - - 8 66.67 - - - - 
4. Severe Pain - - - - - - 3 25 - - - - 
5. Unbearable Pain - - - - - - 1 8.33 - - - - 
           
            The above table 4.3.2 depicts the level of pain perception among patients 
receiving low molecular weight heparin in experimental group and control group 
(left upper outer arm) and the results shows that in experimental group 
immediately after withdrawing needle 12 (92.31%) patients had mild pain and  
1 (7.69%) patient had moderate pain, after 4 hours and 8 hours 13 (100%) of 
patients had no pain respectively, whereas in control group immediately after 
withdrawing needle 8 (66.67%) patients had moderate pain and 3 (25%) patients 
had severe pain and 1 (8.33%) patient had unbearable pain, after 4 hours,  
10 (83.33%) patients had mild pain, 2 (16.67%) patients had no pain, and after  
8 hours 7 (58.33%) patients had no pain, 5 (41.67%) patients had mild pain.          
(Figure 4.3.2.1 and figure 4.3.2.2) 
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Figure 4.3.2.1 
Level of Pain Perception among Patients receiving LMWH in Experimental 
Group (Left Upper Outer Arm) 
 
 
Figure 4.3.2.2 
Level of Pain Perception among Patients receiving LMWH in Control Group 
(Left Upper Outer Arm) 
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Table 4.3.3 
Level of Pain Perception among Patients receiving Low Molecular Weight 
Heparin in Experimental Group and Control Group (Right Thigh) 
(n=25) 
S. 
No 
Pain 
perception 
Right Thigh 
Experimental group (n=13) Control group (n=12) 
Immediat
ely after 
withdrawi
ng needle 
After     
4 Hours 
After     
8 Hours 
Immediat
ely after 
withdrawi
ng needle 
After      
4 Hours 
After     
8 Hours 
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1. No Pain 5 38.46 13 100 13 100 - - 5 41.67 9 75 
2. Mild Pain 7 53.85 - - - - - - 7 58.33 3 25 
3. Moderate Pain 1 7.69 - - - - 10 83.33 - - - - 
4. Severe Pain - - - - - - 2 16.67 - - - - 
5. Unbearable Pain - - - - - - - - - - - - 
            
            The above table 4.3.3 depicts the level of pain perception among patients 
receiving low molecular weight heparin in experimental group and control group 
(right thigh) and the results shows that in experimental group immediately after 
withdrawing needle 7 (53.85%) patients had mild pain, 5 (38.46%) patients had no 
pain, and 1 (7.69%) patient had moderate pain, after  4 hours and 8 hours  
13 (100%) patients had no pain respectively, whereas in control group 
immediately after withdrawing needle 10 (83.33%) patients had moderate pain 
and 2 (16.67%) patients had severe pain, after 4 hours 7 (58.33%) patients had 
mild pain, 5 (41.67%) patients had no pain and after 8 hours 9 (75%) patients had 
no pain, 3 (25%) patients had mild pain. (Figure 4.3.3.1 and Figure 4.3.3.2) 
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Figure 4.3.3.1 
Level of Pain Perception among Patients receiving LMWH in Experimental 
Group (Right Thigh) 
 
 
Figure 4.3.3.2 
Level of Pain Perception Pain Perception among Patients receiving LMWH 
in Control Group (Right Thigh) 
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Table 4.3.4 
Level of Pain Perception among Patients receiving Low Molecular Weight 
Heparin in Experimental Group and Control Group (Left Thigh) 
(n=25) 
S. 
No 
 
Pain 
perception 
Left Thigh 
Experimental group (n=13) Control group (n=12) 
Immedia
tely after 
withdra
wing 
needle 
After     
4 Hours 
After      
8 Hours 
Immed
iately 
after 
withdr
awing 
needle 
After       
4 Hours 
After     
8 Hours 
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1. No Pain 3 23.08 13 100 13 100 - - 2 16.67 7 58.33 
2. Mild Pain 8 61.54 - - - - - - 10 83.33 5 41.67 
3. Moderate Pain 2 15.38 - - - - 6 50 - - - - 
4. Severe Pain - - - - - - 6 50 - - - - 
5. Unbearable Pain - - - - - - - - - - - - 
           
            The above table 4.3.4 depicts the level of pain perception among patients 
receiving low molecular weight heparin in experimental group and control group 
(left thigh) and the results shows that in experimental group immediately after 
withdrawing needle, 8 (61.54%) patients had mild pain, 3 (23.08%) patients had 
no pain and 2 (15.38%) patients had moderate pain, after 4 hours and 8 hours  
13 (100%) patients had no pain respectively, whereas in control group 
immediately after withdrawing needle 6 (50%) patients had moderate pain and 
severe pain respectively, after 4 hours 10 (83.33%) patients had mild pain,  
2 (16.67%)  patients had no pain, and after 8 hours 7 (58.33%)  patients had no 
pain, 5 (41.67%) patients had mild pain. (Figure 4.3.4.1 and Figure 4.3.4.2) 
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Figure 4.3.4.1 
Level of Pain Perception among Patients receiving LMWH in Experimental 
Group (Left Thigh) 
 
 
Figure 4.3.4.2 
Level of Pain Perception among Patients receiving LMWH in Control Group 
(Left Thigh) 
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Section IV 
4.4   Assessment on the Size of Ecchymosis after Dry Cold Application 
among Patients receiving Low Molecular Weight Heparin in 
Experimental Group and Control Group 
            This section deals with the analysis and interpretation assessment on the 
size of ecchymosis after dry cold application among patients receiving low 
molecular weight heparin.  In right upper outer arm, left upper outer arm, right 
thigh and left thigh, the ecchymosis was assessed 48 hours and 72 hours after the 
day of injection by using transparent ruler scale.   
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Table 4.4.1 
Size of Ecchymosis among Patients receiving Low Molecular Weight Heparin 
in Experimental Group and Control Group (Right Upper Outer Arm) 
(n=25) 
S. 
No 
Ecchymosis 
(cm2) 
Right Upper Outer Arm 
Experimental Group (n=13) Control Group (n=12) 
48 hours 72 hours 48 hours 72 hours 
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1. 0 - 0.5 13 100 13 100 9 75 8 66.67 
2. 0.6 - 1.0 - - - - 2 16.67 2 16.67 
3. 1.1 - 1.5 - - - - 1 8.33 1 8.33 
4. 1.6 - 2.0 - - - - - - - - 
5. 2.1 - 2.5 - - - - - - - - 
6. 2.6 - 3.0 - - - - - - 1 8.33 
 
           The above table 4.4.1 depicts the size of ecchymosis among patients 
receiving low molecular weight heparin in experimental group and control group 
(right upper outer arm), the results shows that in the experimental group after  
48 hours and 72 hours 13 (100%)  patients had ecchymosis measuring 0-0.5 cm2, 
whereas in the control group after 48 hours, 9 (75%)  patients had ecchymosis 
measuring 0-0.5 cm2, 2 (16.67%) patients had ecchymosis measuring 0.6 -1.0 cm2  
and 1 (8.33%)  patient had ecchymosis measuring 1.1 -1.5 cm2  and after 72 hours, 
8 (66.67%)  patients had ecchymosis measuring 0-0.5 cm2, 2 (16. 67%)  patients 
had ecchymosis measuring 0.6 -1.0 cm2 and 1 (8.33%) patient had ecchymosis 
measuring 1.1 -1.5 cm2 and 2.6- 3.0 cm2. (Figure 4.4.1.1 and 4.4.1.2) 
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Figure 4.4.1.1 
Size of Ecchymosis among Patients receiving LMWH in Experimental Group 
(Right Upper Outer Arm) 
 
 
Figure 4.4.1.2 
Size of Ecchymosis among Patients receiving Low Molecular Weight Heparin 
in Control Group (Right Upper Outer Arm) 
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Table 4.4.2 
Assessment on the Size of Ecchymosis among Patients receiving Low 
Molecular Weight Heparin in Experimental Group and Control Group (Left 
Upper Outer Arm) 
(n=25) 
S. 
No 
Ecchymosis 
(cm2) 
Left Upper Outer Arm 
Experimental Group (n=13) Control Group (n=12) 
48 hours 72 hours 48 hours 72 hours 
Fr
eq
ue
nc
y 
Pe
rc
en
ta
ge
 
(%
) 
Fr
eq
ue
nc
y 
Pe
rc
en
ta
ge
 
(%
) 
Fr
eq
ue
nc
y 
Pe
rc
en
ta
ge
 
(%
) 
Fr
eq
ue
nc
y 
Pe
rc
en
ta
ge
 
(%
) 
1. 0 - 0.5 13 100 13 100 10 83.34 8 66.67 
2. 0.6 - 1.0 - - - - - - 2 16.67 
3. 1.1 - 1.5 - - - - 1 8.33 1 8.33 
4. 1.6 - 2.0 - - - - 1 8.33 - - 
5. 2.1 - 2.5 - - - - - - - - 
6. 2.6 - 3.0 - - - - - - 1 8.33 
 
           The above table 4.4.2 depicts the size of ecchymosis among patients 
receiving low molecular weight heparin in experimental group and control group 
(left upper outer arm), the results shows that in the experimental group after  
48 hours and 72 hours 13 (100%)  patients had ecchymosis measuring 0-0.5 cm2, 
whereas in the control group after 48 hours, 10 (83.34%)  patients had ecchymosis 
measuring  0-0.5 cm2, 1 (8.33%)  patient had ecchymosis measuring 1.1 -1.5 cm2  
and 1.6 -2.0 cm2 respectively and after 72 hours, 8 (66.67%)  patients had 
ecchymosis measuring 0-0.5 cm2, 2 (16.67%) patients had ecchymosis measuring 
0.6 -1.0 cm2 and 1 (8.33%) patient had ecchymosis measuring 1.1 -1.5 cm2 and 
2.6- 3.0 cm2. (Figure 4.4.2.1 and Figure 4.4.2.2) 
 The ecchymosis among patients receiving low molecular weight heparin in 
experimental group and control group on right and left thigh, the results shows 
that in the experimental group and control group after 48 hours and 72 hours  
13 (100%) patients had ecchymosis measuring 0-0.5 cm2. 
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Figure 4.4.2.1 
Size of Ecchymosis among Patients receiving LMWH in Experimental Group 
(Left Upper Outer Arm) 
 
 
Figure 4.4.2.2 
Size of Ecchymosis among Patients receiving LMWH in Control Group           
(Left Upper Outer Arm) 
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Section V 
4.5  Effect of Dry Cold Application on Pain Perception among Patients 
receiving Low Molecular Weight Heparin in the Experimental Group 
and Control Group  
 This section deals with the analysis and interpretation on effect of dry cold 
application on pain perception among patients receiving low molecular weight 
heparin.  The pain perception was assessed immediately after withdrawing needle, 
4 hours, and 8 hours in the right upper outer arm, left upper outer arm, right thigh 
and left thigh, by using numerical pain rating scale.  
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Table 4.5.1 
Comparison on the Effect of Dry Cold Application on Pain Perception among 
Patients receiving Low Molecular Weight Heparin in                           
Experimental Group and Control Group 
 
Pain Perception Group Mean SD 
Mean 
difference 
't' 
value 
 
Right 
Upper 
Outer 
Arm 
Immediately 
after      
withdrawing 
needle 
Experimental 
Group 1.462 0.812 3.897 10.667* 
Control Group 5.359 0.938 
After 
4 Hours 
 
Experimental 
Group 0 0 0.693 3.808* 
Control Group 0.693 0.63 
After 
8 Hours 
 
Experimental 
Group 0 0 0.222 3.083* 
Control Group 0.222 0.249 
Left 
Upper 
Outer 
Arm 
Immediately 
after      
withdrawing 
needle 
Experimental 
Group 1.667 0.995 4.221 9.058* 
Control Group 5.888 1.235 
 
After 
4 Hours 
 
Experimental 
Group 0 0 
0.916 4.468* 
Control Group 0.916 0.708 
 
 
8 Hours 
 
Experimental 
Group 0 0 0.306 2.684* 
Control Group 0.306 0.397 
Right 
Thigh 
Immediately 
after      
withdrawing 
needle 
Experimental 
Group 1.231 1.137 4.019 8.023* 
Control Group 5.25 1.267 
 
After 
4 Hours 
 
Experimental 
Group 0 0 0.708 2.878* 
Control Group 0.708 0.853 
After 
8 Hours 
 
Experimental 
Group 0 0 0.375 2.232* 
Control Group 0.375 0.582 
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Pain Perception Group Mean SD 
Mean 
difference 
't' 
value 
Left 
Thigh 
Immediately 
after      
withdrawing 
needle 
Experimental 
Group 1.346 1.182 4.487 8.798* 
Control Group 5.833 1.264 
 
After 
4 Hours 
 
Experimental 
Group 0 0 1.208 5.207* 
Control Group 1.208 0.802 
 
After 
8 Hours 
 
Experimental 
Group 0 0 
0.292 2.679* 
Control Group 0.292 0.379 
*Significant at 0.05 level 
            Unpaired 't' test was used to compare the effect of dry cold application on 
pain perception among patients receiving LMWH in experimental and control 
groups.     
           The pain perception was assessed in right upper outer arm, immediately 
after withdrawing needle, the mean score and standard deviation of experimental 
group was 1.462 and 0.812 respectively, and control group was 5.359 and 0.938 
respectively with the mean difference of 3.897, and after 4 hours, the mean score 
and standard deviation of experimental group was 0 and control group was 0.693 
and 0.63 respectively with the mean difference of 0.693 and after 8 hours, the 
mean score and standard deviation of experimental group was 0 and control group 
was 0.222 and 0.249 respectively with the mean difference of 0.222. Calculated  
µW¶ YDOXH immediately after withdrawing the needle, 4 hours, and 8 hours were 
10.667, 3.808 and 3.083 respectively which was greater than the table value  
(tv= 2.07, df=23) at 0.05 level of significance. Hence it shows there is a significant 
difference in the level of pain perception among patients receiving LMWH on 
right upper outer arm in the experimental and control group. 
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            The pain perception was assessed in left upper outer arm, immediately 
after withdrawing needle, it was identified that, the mean score and standard 
deviation of experimental group was 1.667 and 0.995 respectively, and control 
group was 5.888 and 1.235 respectively with the mean difference of 4.221, and 
after 4 hours, it was identified that, the mean score and standard deviation of 
experimental group was 0 and control group was 0.916 and 0.708 respectively 
with the mean difference of 0.916, and after 8 hours, it was identified that, the 
mean score and standard deviation of experimental group was 0 and control group 
was 0.306 and 0.397 respectively with the mean difference of 0.306. Calculated  
µW¶ YDOXH immediately after withdrawing the needle, 4 hours, and 8 hours were 
9.058, 4.468, and 2.684 respectively which was greater than the table value  
(tv= 2.07, df=23) at 0.05 level of significance. Hence it shows there is a significant 
difference in the level of pain perception among patients receiving LMWH on left 
upper outer arm in the experimental and control group. 
            The pain perception was assessed in right thigh, immediately after 
withdrawing needle, it was identified that, the mean score and standard deviation 
of experimental group was 1.231 and 1.137 respectively, and control group was 
5.25 and 1.267 respectively with the mean difference of 4.019, and after 4 hours, 
it was identified that, the mean score and standard deviation of experimental 
group was 0, and control group was 0.708 and 0.853 respectively with the mean 
difference of 0.708, and after 8 hours, it was identified that, the mean score and 
standard deviation of experimental group was 0, and control group was 0.375 and 
0.582 respectively with the mean difference of 0.375. &DOFXODWHG µW¶ YDOXH
immediately after withdrawing the needle, 4 hours, and 8 hours were 8.023, 2.878, 
and 2.232 respectively which was greater than the table value (tv= 2.07, df=23) at 
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0.05 level of significance. Hence it shows there is a significant difference in the 
level of pain perception among patients receiving LMWH on right thigh in the 
experimental and control group. 
            The pain perception was assessed in left thigh, immediately after 
withdrawing needle, it was identified that, the mean score and standard deviation 
of experimental group was 1.346 and 1.182 respectively, and control group was 
1.833 and 1.264 respectively with the mean difference of 4.487, and after 4 hours, 
it was identified that, the mean score and standard deviation of experimental 
group was 0, and control group was 1.208 and 0.802 respectively with the mean 
difference of 1.208, and 8 hours it was identified that, the mean score and standard 
deviation of experimental group was 0, control group was 0.292 and 0.379 
respectively with the mean difference of 0.292. &DOFXODWHGµW¶YDOXH immediately 
after withdrawing the needle, 4 hours, and 8 hours were 8.798, 5.207 and 2.679 
respectively which was greater than the table value (tv= 2.07, df=23) at 0.05 level 
of significance. Hence it shows there is a significant difference in the level of pain 
perception among patients receiving LMWH on left thigh in the experimental and 
control group. (Figure 4.5.1.1, Figure 4.5.1.2, Figure 4.5.1.3 and Figure 4.5.1.4) 
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Figure 4.5.1.1 
Comparison on the Effect of Dry Cold Application on Pain Perception among 
Patients receiving LMWH in Experimental Group and Control Group (Right 
Upper Outer Arm) 
 
 
Figure 4.5.1.2 
Comparison on the Effect of Dry Cold Application on Pain Perception among 
Patients receiving LMWH in Experimental Group and Control Group           
(Left Upper Outer Arm) 
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Figure 4.5.1.3 
Comparison on the Effect of Dry Cold Application on Pain Perception among 
Patients receiving LMWH in Experimental Group and Control Group  
(Right Thigh) 
 
Figure 4.5.1.4 
Comparison on the Effect of Dry Cold Application on Pain Perception among 
Patients receiving LMWH in Experimental Group and Control Group            
(Left Thigh) 
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Table 4.5.2 
Effect of Dry Cold Application on Pain Perception among Patients receiving 
Low Molecular Weight Heparin in the Experimental Group and                   
Control Group 
S. 
No Pain Perception Group Mean SD 
Mean 
difference 
't' 
value 
1. 
Immediately 
after      
withdrawing 
needle 
Experimental 
Group 0.439 0.555 
1.422 2.205* 
Control Group 1.861 2.155 
2. After 4 Hours 
Experimental 
Group 0 0 
0.294 2.827* 
Control Group 0.294 0.359 
3. After 8 Hours 
Experimental 
Group 0 0 
0.099 2.912* 
Control Group 0.099 0.119 
*Significant at 0.05 level 
            The above table 4.5.2 depicts the mean values of each sites (right upper 
outer arm, left upper outer arm, right thigh and left thigh), of pain perception, 
immediately after withdrawing needle, 4 hours and 8 hours in the experimental 
and control group.  Unpaired 't' test was used to analyze the effect of dry cold 
application on pain perception among patients receiving LMWH in experimental 
and control groups.  
Level of pain perception was assessed immediately after withdrawing 
needle, it was identified that, the mean score and standard deviation of 
experimental group was 0.439 and 0.555 respectively and control group was 1.861 
and 2.155 respectively with the mean difference of 1.422. &DOFXODWHGµW¶YDOXHZDV
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2.205, which was greater than the table value (tv= 2.07, df=23) at 0.05 level of 
significance. Pain perception assessed after 4 hours, it was identified that, the 
mean score and standard deviation of experimental group was 0 and control group 
0.294 and 0.359 respectively with the mean difference of 0.294. &DOFXODWHG µW¶
value was 2.827, which was greater than the table value (tv= 2.07, df=23)  
at 0.05 level of significance. Pain perception assessed after 8 hours, it was 
identified that, the mean score and standard deviation of experimental group  
was 0 and the control group was 0.099 and 0.119 respectively with the mean 
difference of 0.099. &DOFXODWHG µW¶ YDOXHZDV , which was greater than the 
table value (tv= 2.07, df=23) at 0.05 level of significance. Hence it shows there is 
a significant difference in the level of pain perception among patients receiving 
LMWH in immediately after withdrawing needle, after 4 hours and after 8 hours 
in the experimental and control group. (Figure 4.5.2) 
Thus the research hypothesis, H1: There will be a significant difference in 
the level of pain perception between the experimental group and control group 
after dry cold application among patients receiving low molecular weight heparin 
is accepted. 
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Figure 4.5.2 
Effect of Dry Cold Application on Pain Perception among Patients receiving 
LMWH in the Experimental Group and Control Group 
 
 
Section VI 
4.6 Effect of Dry Cold Application on Ecchymosis among Patients 
receiving LMWH in the Experimental Group and Control Group 
This section deals with the analysis and interpretation on effect of dry cold 
application on ecchymosis among patients receiving low molecular weight 
heparin.  In right upper outer arm, left upper outer arm, right thigh and left thigh, 
the ecchymosis was assessed 48 hours and 72 hours after the day of injection by 
using transparent ruler scale.  
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Table 4.6.1 
Comparison on the Effect of Dry Cold Application on Ecchymosis among 
Patients receiving Low Molecular Weight Heparin in  
Experimental Group and Control Group 
Ecchymosis  
Group Mean (cm2) SD 
Mean 
difference 
't' 
value Site Hours 
Right 
Upper 
Outer 
Arm 
48 hours 
Experimental 
Group 0.005 0 0.324 2.769* 
Control Group 0.329 0.402 
72 hours 
Experimental 
Group 0.003 0 0.512 2.498* 
Control Group 0.515 0.711 
Left 
Upper 
Outer 
Arm 
48 hours 
Experimental 
Group 0.007 0 0.324 2.189* 
Control Group 0.331 0.511 
72 hours 
Experimental 
Group 0.003 0 0.549 2.589* 
Control Group 0.552 0.736 
Right 
Thigh 
48 hours 
Experimental 
Group 0.009 0 0.11 3.667* 
Control Group 0.119 0.105 
72 hours 
Experimental 
Group 0.005 0.009 0.155 2.87* 
Control Group 0.16 0.185 
Left 
Thigh 
48 hours 
Experimental 
Group 0.008 0.009 0.038 2.11* 
Control Group 0.046 0.061 
72 hours 
Experimental 
Group 0.004 0 0.08 2.857* 
Control Group 0.084 0.099 
*Significant at 0.05 level 
 Unpaired µW¶WHVWZDVXVHGWRFRPSDUHWKHHIIHFWRIGU\FROGDSSOLFDWLRQRQ
ecchymosis among patients receiving LMWH in the experimental group and 
control groups.  
Ecchymosis was assessed in right upper outer arm, 48 hours after the day 
of injection, it was identified that, the mean score and standard deviation of 
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experimental group was 0.005 and 0 and control group was 0.329 and  
0.402 respectively with the mean difference of 0.324, and 72 hours after the day 
of injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.003 and 0 and, control group was 0.515 and  
0.711 respectively with the mean difference of 0.512. CalculDWHG µW¶ YDOXH 48 
hours and 72 hours after the day of injection were 2.769 and 2.498 respectively, 
which was greater than the table value (tv= 2.07, df=23) at 0.05 level of 
significance. Hence it shows there is a significant difference in the size of 
ecchymosis among patients receiving LMWH on right upper outer arm, 48 hours 
and 72 hours after the day of injection.          .  
           Ecchymosis was assessed in left upper outer arm, 48 hours after the day of 
injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.007 and 0 respectively, and control group was 0.331 
and 0.511 respectively with the mean difference of 0.324, and 72 hours after the 
day of injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.003 and 0 respectively, control group was 0.552 and 
0.736 respectively with the mean difference of 0.549. &DOFXODWHG µW¶ YDOXH 
48 hours and 72 hours after the day of injection were 2.189 and 2.589 respectively 
which was greater than the table value (tv= 2.07, df=23) at 0.05 level of 
significance. Hence it shows there is a significant difference in the size of 
ecchymosis among patients receiving LMWH on left upper outer arm, 48 hours 
and 72 hours after the day of injection. 
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 Ecchymosis was assessed in right thigh, 48 hours after the day of injection, 
it was identified that, the mean score and standard deviation of experimental 
group was 0.009 and 0 respectively and control group was 0.119 and 0.105 
respectively with the mean difference of 0.11, and 72 hours after the day of 
injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.005 and 0.009 respectively and control group was  
0.16 and 0.185 respectively with the mean difference of 0.155. Calculated µW¶
value 48 hours and 72 hours after the day of injection were 3.667 and 2.87 
respectively, which was greater than the table value (tv= 2.07, df=23) at 0.05 level 
of significance. Hence it shows there is a significant difference in the size of 
ecchymosis among patients receiving LMWH on right thigh, 48 hours and  
72 hours after the day of injection. 
          Ecchymosis was assessed in left thigh, 48 hours after the day of injection, it 
was identified that, the mean score and standard deviation of experimental group 
was 0.008 and 0.009 respectively, and control group was 0.046 and 0.061 
respectively with the mean difference of 0.038 and 72 hours after the day of 
injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.004 and 0 respectively, and control group was 0.084 
and 0.099 respectively with the mean difference of 0.08. &DOFXODWHG µW¶ YDOXH  
48 hours and 72 hours after the day of injection were 2.11 and 2.857, which was 
greater than the table value (tv= 2.07, df=23) at 0.05 level of significance. Hence it 
shows there is a significant difference in the size of ecchymosis among patients 
receiving LMWH on left thigh, 48 hours and 72 hours after the day of injection. 
(Figure 4.6.1.1, Figure 4.6.1.2, Figure 4.6.1.3 and Figure 4.6.1.4) 
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Figure 4.6.1.1 
Comparison on the Effect of Dry Cold Application on Ecchymosis among 
Patients receiving LMWH in Experimental Group and Control Group  
(Right Upper Outer Arm) 
 
Figure 4.6.1.2 
Comparison on the Effect of Dry Cold Application on Ecchymosis among 
Patients receiving LMWH in Experimental Group and Control Group           
(Left Upper Outer Arm) 
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Figure 4.6.1.3 
Comparison on the Effect of Dry Cold Application on Ecchymosis among 
Patients receiving LMWH in Experimental Group and Control Group  
(Right Thigh) 
 
Figure 4.6.1.4 
Comparison on the Effect of Dry Cold Application on Ecchymosis among 
Patients receiving LMWH in Experimental Group and Control Group        
(Left Thigh) 
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Table 4.6.2 
Effect of Dry Cold Application on Ecchymosis among Patients Receiving Low 
Molecular Weight Heparin in the Experimental Group and Control Group 
 
S. 
No Ecchymosis Group 
Mean 
(cm2) 
SD Mean difference 
't' 
value 
1. 48 hours 
Experimental Group 0.003 0 
0.066 2.129* 
Control Group 0.069 0.108 
2. 72 hours 
Experimental Group 0.001 0 
0.108 2.118* 
Control Group 0.109 0.175 
*Significant at 0.05 level 
            The above table 4.6.2 depicts the mean values in each site (right upper 
outer arm, left upper outer arm, right thigh and left thigh) of ecchymosis after 48 
hours and 72 hours in the experimental and control group. Unpaired 't' test was 
used to analyze effect of dry cold application on ecchymosis among patients 
receiving LMWH in experimental and control groups.  
Size of ecchymosis was assessed 48 hours after the day of injection, it was 
identified that, the mean score and the standard deviation of experimental group 
was 0.003 and 0 respectively and control group was 0.069 and 0.108 respectively 
with the mean difference of 0.066. Calculated µW¶ YDOXH ZDV , which was 
greater than the table value (tv= 2.07, df=23) at 0.05 level of significance. 
Ecchymosis assessed 72 hours after the day of injection, it was identified that, the 
mean score and the standard deviation of experimental group was 0.001 and 0 and 
control group was 0.109 and 0.175 respectively with the mean difference of 
0.108. &DOFXODWHG µW¶ YDOXH ZDV , which was greater than the table value  
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(tv= 2.07, df=23) at 0.05 level of significance. Hence it shows there is a significant 
difference in the size of ecchymosis among patients receiving LMWH in  
48 hours and 72 hours after the day of injection. (Figure 4.6.2) 
Thus the research hypothesis H2: There will be a significant difference in 
the size of ecchymosis between the experimental group and control group after 
dry cold application among patients receiving low molecular weight heparin is 
accepted. 
Figure 4.6.2 
Effect of Dry Cold Application on Ecchymosis among Patients Receiving 
LMWH in the Experimental Group and Control Group 
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RESULTS AND DISCUSSION  
 
  This chapter deals with the results and discussion and findings. The aim of 
the study was to determine the effect of dry cold application on pain perception and 
ecchymosis among patients receiving low molecular weight heparin. The samples of 
the study were patients receiving injection low molecular weight heparin in  
Sri Ramakrishna Hospital. Total enumerative sampling technique was used to select 
the samples were randomly assigned to experimental group (n=13) and control group 
(n=12). For experimental group dry cold application was given for 3 minutes prior to 
administration of low molecular weight heparin. Injection LMWH was administered 
subcutaneously to the experimental group and control group. The level of pain 
perception was assessed by using numerical pain rating scale. The ecchymosis was 
assessed by using transparent ruler scale. The findings were discussed under the 
following headings. 
5.1 Findings Related to Demographic Variables 
 The age of patients receiving low molecular weight heparin shows that in 
experimental group 9 (69.23%) patients were above 51 years, 3 (23.08%) patients 
were between the age group of 41 and 50 years, 1 (7.69%) patient was below 30 years 
and in the control group 8 (66.67%) patients were above 51 years, 2 (16.67%) 
patients were in the age group of 31 and 40 years, 1 (8.33%) patient was below  
30 years and 41-50 years respectively.  
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 The gender of patients receiving low molecular weight heparin shows that in 
the experimental group 10 (76.92%) patients were males, 3 (23.08%) patients were 
females, and in the control group 6 (50%) patients were males and females 
respectively.  
 The educational status of patients receiving low molecular weight heparin 
shows that in the experimental group, 3 (23.08%) patients had higher secondary 
education, 6 (46.15%) patients had high school education, 3 (23.08%) patients had 
primary school education and 1 (7.69%) patient was illiterate and in the control group 
2 (16.67%) patients were graduates, 3 (25%) patients had higher secondary education, 
5 (41.67%) patients had high school education, 1 (8.33%) patient had primary school 
education and 1 (8.33%) patient was illiterate.  
 The marital status of patients receiving low molecular weight heparin reveals 
that in the experimental group 11 (84.62%) patients were married, 1 (7.69%) patient 
was single and 1 (7.69%) patient was a widow and in the control group 9 (75%) 
patients were married, 2 (16.67%) patients were widows and 1 (8.33%) patient was 
single.  
 The religion of patients receiving low molecular weight heparin reveals that 
majority of patients, 13 (100%) in experimental group and 10 (83.33%) in control 
group belonged to Hindu religion 
 The occupation of patients receiving low molecular weight heparin shows 
that, in the experimental group 9 (69.23%) patients were employed, 4 (30.77%) were 
unemployed and in the control group 6 (50%) patients were employed and 
unemployed respectively.  
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5.2 Findings Related to Clinical Variables 
 The diagnosis of patients receiving low molecular weight heparin reveals that, 
in the experimental group 10 (76.92%) patients were the diagnosed with CVA, 
2 (15.39%) patients were diagnosed with other diseases such as autoimmune 
encephalitis, seizure disorder and 1 (7.69%) patient was diagnosed with DVT and in 
the control group 8 (66.67%) patients were diagnosed with CVA, 2 (16.67%) patients 
were diagnosed with cerebro vascular thrombosis, 1(8.33%) patient was diagnosed 
with deep vein thrombosis, 1 (8.33%) patient was diagnosed with hepatoma.  
 The name of injection LMWH received by patients shows that in the 
experimental group 8 (61.53%) patients received Inj. Flothin 40 mg, 2 (15.39%) 
patients received Inj. Lupenox 40 mg, and Inj. Clexane 40 mg respectively, 1 (7.69%) 
patient received Inj. Enox 40 mg, and in the control group 8 (66.67%) patients 
received Inj. Flothin 40 mg, 2 (16.67%) patients received Inj. Enox 40 mg, 1 (8.33%) 
patient received Inj. Lupenox 40 mg, and Inj. Clexane 40 mg respectively. 
 The frequency of low molecular weight heparin received by patients shows 
that in the experimental and control group, 100% of patients received inj. LMWH 
twice a day. 
 Melba & Priyalatha (2009) conducted a study on the effectiveness of dry cold 
application on the occurrence of bruising and pain at the subcutaneous injection site 
of LMWH among 60 patients. The majority of patients were between the age of  
51-60 years about 52 (86.7%) were males and 8 (13.3%) were females. The majority 
32 (53.33%) received injection LMWH twice a day and 28 (46.67%) received 
injection LMWH once a day. 
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 The patients receiving LMWH based on presence of any other illness reveals 
that in the experimental group 10 (76.92%) patients had other illness, 3 (23.08%) 
patients had no other illness and in the control group 6 (50%) patients had other 
illness, 6 (50%) patients had no other illness such as DM, SHT, CCF, IHD, CHF, 
CRF, PVD etc.    
Batra (2014) conducted a study on the application of ice cube prior to 
subcutaneous injection of heparin in pain perception and ecchymosis of patients with 
cardiovascular problems. It was a quasi-experimental study posttest only control 
group design with 30 experimental group and 30 control group patients. The result 
shows, that in the experimental group 46.7% patients were 45-55 years of age. 
According to the gender, in experimental group majority 53.3% were males whereas 
in control group 76.7% patients were males. And the marital status, in experimental 
and control group 100% were married. According to the religion, in experimental 
group 70% and control group 80% patients belonged to Hindu religion. In 
experimental group 73.33% and control group 63.33% patients received 40 mg 
injection LMWH. In experimental group 33.3% and control group 36.7% patients 
were having hypertension and CAD. 
5.3     Assessment on the Level of Pain Perception among Patients receiving 
Low Molecular Weight Heparin in the Experimental Group and Control 
Group 
 In this study 13 patients receiving dry cold application prior to administration 
of low molecular weight heparin and 12 patients not receiving dry cold application 
prior to administration of low molecular weight heparin were assessed for the level of 
pain perception experienced by using numerical pain rating scale.  
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            The level of pain perception among patients receiving LMWH on right upper 
outer arm shows that in the experimental group immediately after withdrawing 
needle, 13 (100%) patients had mild pain, after 4 hours and 8 hours 13 (100%) 
patients had no pain respectively, whereas in the control group immediately after 
withdrawing needle 8 (66.67%) patients had moderate pain and 4 (33.33%) had 
severe pain, after 4 hours 8 (66.67%) patients had mild pain, 4 (33.33 %) patients had 
no pain, and after 8 hours 6 (50%) patients had no pain and mild pain respectively.           
 The level of pain perception among patients receiving LMWH in left upper 
outer arm reveals that in experimental group immediately after withdrawing needle 
12 (92.31%) patients had mild pain and 1 (7.69%) patient had moderate pain, after  
4 hours and 8 hours 13 (100%) of patients had no pain respectively, whereas in 
control group immediately after withdrawing needle 8 (66.67%) patients had 
moderate pain and 3 (25%) patients had severe pain and 1 (8.33%) patient had 
unbearable pain, after 4 hours 10 (83.33%) patients had mild pain, 2 (16.67%) 
patients had no pain, and after 8 hours 7 (58.33%) patients had no pain, 5 (41.67%) 
patients had mild pain.            
The level of pain perception among patients receiving LMWH in right thigh 
shows that in experimental group immediately after withdrawing needle 7 (53.85%) 
patients had mild pain, 5 (38.46%) patients had no pain, and 1 (7.69%) patient had 
moderate pain, after 4 hours and 8 hours 13 (100%) patients had no pain respectively, 
whereas in control group immediately after withdrawing needle 10 (83.33%) patients 
had moderate pain and 2 (16.67%) patients had severe pain, after 4 hours 7 (58.33%) 
patients had mild pain, 5 (41.67 %) patients had no pain, and after 8 hours 9 (75%) 
patients had no pain, 3 (25%) patients had mild pain. 
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 The level of pain perception among patients receiving LMWH in left thigh 
reveals that in experimental group immediately after withdrawing needle 8 (61.54%) 
patients had mild pain, 3 (23.08%) patients had no pain, and 2 (15.38%) patients had 
moderate pain, after 4 hours and 8 hours 13 (100%) patients had no pain respectively, 
whereas in control group immediately after withdrawing needle 6 (50%) patients had 
moderate pain and severe pain respectively, after 4 hours 10 (83.33%)  patients had 
mild pain, 2 (16.67%)  patients had no pain, and after 8 hours 7 (58.33%)  patients 
had no pain, 5 (41.67%) patients had mild pain. 
5.4 Assessment on the Size of Ecchymosis after Dry Cold Application among 
Patients receiving LMWH in Experimental Group and Control Group 
The size of ecchymosis among patients receiving LMWH on right upper outer 
arm shows that in the experimental group, after 48 hours and 72 hours 13 (100%)  
patients had ecchymosis measuring 0- 0.5 cm2, whereas in the control group after  
48 hours, 9 (75%) patients had ecchymosis measuring 0-0.5 cm2 ecchymosis,  
2 (16.67%) patients had ecchymosis measuring 0.6 -1.0 cm2  and 1 (8.33%)  patient 
had ecchymosis measuring 1.1 -1.5 cm2 and after 72 hours, 8 (66.67%) patients had 
ecchymosis measuring 0-0.5 cm2, 2 (16.67%)  patients had ecchymosis measuring   
0.6 -1.0 cm2 and  1 (8.33%) patient had ecchymosis measuring 1.1 -1.5 cm2 and  
2.6- 3.0 cm2. 
The size of ecchymosis among patients receiving LMWH on left upper outer 
arm shows that in the experimental group, after 48 hours and 72 hours 13 (100%)  
patients had ecchymosis measuring 0-0.5 cm2, whereas in the control group after  
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48 hours, 10 (83.34%)  patients had ecchymosis measuring 0-0.5 cm2, 1 (8.33%)  
patient had ecchymosis measuring 1.1 -1.5 cm2  and 1.6 -2.0 cm2  respectively and 
after 72 hours 8 (66.67%)  patients had ecchymosis measuring 0-0.5cm2, 2 (16.67%)  
patients had ecchymosis measuring  0.6-1.0 cm2 and 1 (8.33%) patient had 
ecchymosis measuring 1.1 -1.5 cm2 and 2.6- 3.0 cm2. 
 The ecchymosis among patients receiving LMWH on right and left thigh 
shows that in the experimental group and control group after 48 hours and 72 hours 
13 (100%) patients had ecchymosis measuring 0- 0.5 cm2.  
5.5  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving Low Molecular Weight Heparin in the Experimental and 
Control Group. 
 In this study 25 patients experimental group 13 patients and control group  
12 patients were analyzed to evaluate the effect of dry cold application on pain 
perception among patients receiving low molecular weight. Unpaired 't' test was used 
to compare the effect of dry cold application on pain perception among patients 
receiving LMWH in experimental and control group.  
           The effect of dry cold application on pain perception in right upper outer arm, 
immediately after withdrawing needle, the mean score and standard deviation of 
experimental group was 1.462, 0.812 respectively, and control group was 5.359, 
0.938 respectively with the mean difference of 3.897, after 4 hours, the mean score 
and standard deviation of experimental group was 0 and control group was 0.693 and 
0.63 respectively with the mean difference of 0.693 and after 8 hours, the mean score 
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and standard deviation of experimental group was 0 and control group was 0.222 and 
0.249 respectively with the mean difference of 0.222. &DOFXODWHG µW¶ YDOXH
immediately after withdrawing the needle, at 4 hours, and 8 hours were 10.667,  
3.808 and 3.083 respectively which was greater than the table value (tv= 2.07, df=23) 
at 0.05 level of significance. 
            The effect of dry cold application on pain perception in left upper outer arm, 
immediately after withdrawing needle, it was identified that, the mean score and 
standard deviation of experimental group was 1.667 and 0.995 respectively, and 
control group was 5.888 and 1.235 respectively with the mean difference of  
4.221, and after 4 hours, it was identified that, the mean score and standard deviation 
of experimental group was 0  and control group was 0.916 and 0.708 respectively 
with the mean difference of 0.916, and after 8 hours, it was identified that, the mean 
score and standard deviation of experimental group was 0 and control group was 
0.306 and 0.397 UHVSHFWLYHO\ZLWKWKHPHDQGLIIHUHQFHRI&DOFXODWHGµW¶YDOXH
immediately after withdrawing the needle, 4 hours, and 8 hours were 9.058, 4.468, 
and 2.684 respectively which was greater than the table value (tv= 2.07, df=23) at 
0.05 level of significance. 
            The effect of dry cold application on pain in right thigh, immediately after 
withdrawing needle, it was identified that, the mean score and standard deviation of 
experimental group was 1.231 and 1.137 respectively, and control group was 5.25 and 
1.267 respectively with the mean difference of 4.019, and after 4 hours, it was 
identified that, the mean score and standard deviation of experimental group  
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was 0, and control group was 0.708 and 0.853 respectively with the mean difference 
of 0.708, and after 8 hours, it was identified that, the mean score and standard 
deviation of experimental group was 0, and control group was 0.375 and 0.582 
respecWLYHO\ZLWKWKHPHDQGLIIHUHQFHRI&DOFXODWHGµW¶YDOXHLPPHGLDWHO\DIWHU
withdrawing the needle, 4 hours, and 8 hours were 8.023, 2.878, and 2.232 
respectively which was greater than the table value (tv= 2.07, df=23) at 0.05 level of 
significance. 
            The effect of dry cold application on pain perception in left thigh, 
immediately after withdrawing needle, it was identified that, the mean score and 
standard deviation of experimental group was 1.346 and 1.182 respectively, and 
control group was 1.833 and 1.264 respectively with the mean difference of 4.487, 
and after 4 hours, it was identified that, the mean score and standard deviation of 
experimental group was 0, and control group was 1.208 and 0.802 respectively with 
the mean difference of 1.208, and 8 hours, it was identified that, the mean score and 
standard deviation of experimental group was 0, and control group was 0.292 and 
 UHVSHFWLYHO\ ZLWK WKH PHDQ GLIIHUHQFH RI  &DOFXODWHG µW¶ YDOXH
immediately after withdrawing the needle, 4 hours, and 8 hours were 8.798, 5.207 and 
2.679 respectively which was greater than the table value (tv= 2.07, df=23) at 0.05 
level of significance.       
       Hence it shows there is a significant difference in the level of pain perception 
among patients receiving LMWH on right upper outer arm, left upper outer arm, right 
thigh, and left thigh in immediately after withdrawing the needle, after 4 hours, and 
after 8 hours after dry cold application 
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            Effect of dry cold application on level of pain perception immediately after 
withdrawing needle, it was identified that, the mean score and standard deviation of 
experimental group was 0.439 and 0.555 respectively and control group was 1.861 
and 2.155 respectively with the mean difference of 1.&DOFXODWHG µW¶YDOXHZDV
2.205, which was greater than the table value (tv= 2.07, df=23) at 0.05 level of 
significance. Pain perception assessed after 4 hours, it was identified that, the mean 
score and standard deviation of experimental group was 0 and control group 0.294 
DQG UHVSHFWLYHO\ZLWK WKHPHDQGLIIHUHQFHRI&DOFXODWHG µW¶YDOXHZDV
2.827, which was greater than the table value (tv= 2.07, df=23)  
at 0.05 level of significance. Pain perception assessed after 8 hours, it was identified 
that, the mean score and standard deviation of experimental group  
was 0 and the control group was 0.099 and 0.119 respectively with the mean 
GLIIHUHQFHRI&DOFXODWHGµW¶YDOXHZDVZKLFKZDVJUHDWHUWKDQWKHWDEOH
value (tv= 2.07, df=23) at 0.05 level of significance.  
            Hence it shows there is a significant difference in the level of pain perception 
among patients receiving LMWH in immediately after withdrawing the needle, after 
4 hours, and after 8 hours after dry cold application. Thus the research hypothesis,  
H1: There will be a significant difference in the level of pain perception between the 
experimental group and control group after dry cold application among patients 
receiving low molecular weight heparin is accepted. 
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5.6  Effect of Dry Cold Application on Ecchymosis among Patients receiving 
Low Molecular Weight Heparin in the Experimental and Control Group. 
            8QSDLUHG µW¶ WHVWZDV XVHG WR FRPSDUH WKH HIIHFW RI GU\ FROG DSSOLFDWLRQ on 
ecchymosis among patients receiving LMWH in the experimental group and control 
groups.  
Effect of dry cold application on ecchymosis in right upper outer arm,                      
48 hours after the day of injection, it was identified that, the mean score and standard 
deviation of experimental group was 0.005 and 0 and control group was 0.329 and 
0.402 respectively with the mean difference of 0.324, and 72 hours after the day of 
injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.003 and 0 and, control group was 0.515 and 0.711 
UHVSHFWLYHO\ ZLWK WKHPHDQ GLIIHUHQFH RI  &DOFXODWHG µW¶ YDOXH  KRXUV DQG           
72 hours after the day of injection were 2.769 and 2.498 respectively, which was 
greater than the table value (tv= 2.07, df=23) at 0.05 level of significance.   
 Effect of dry cold application on ecchymosis in left upper outer arm, 48 hours 
after the day of injection, it was identified that, the mean score and standard deviation 
of experimental group was 0.007 and 0 respectively, and control group was 0.331 and 
0.511 respectively with the mean difference of 0.324, and 72 hours after the day of 
injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.003 and 0 respectively, control group was 0.552 and 0.736 
respectiveO\ ZLWK WKHPHDQ GLIIHUHQFH RI  &DOFXODWHG µW¶ YDOXH  KRXUV DQG 
72 hours after the day of injection were 2.189 and 2.589 respectively which was 
greater than the table value (tv= 2.07, df=23) at 0.05 level of significance. 
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 Effect of dry cold application on ecchymosis in right thigh, 48 hours after the 
day of injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.009 and 0 respectively and control group was 0.119 and 
0.105 respectively with the mean difference of 0.11, and 72 hours after the day of 
injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.005 and 0.009 respectively and control group was 0.16 and 
0.185 respectively with the PHDQGLIIHUHQFHRI&DOFXODWHG µW¶YDOXHKRXUV
and 72 hours after the day of injection were  3.667 and 2.87 respectively, which was 
greater than the table value (tv= 2.07, df=23) at 0.05 level of significance. 
          Effect of dry cold application on ecchymosis in left thigh, 48 hours after the 
day of injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.008 and 0.009 respectively, and control group was 0.046 
and 0.061 respectively with the mean difference of 0.038 and 72 hours after the day 
of injection, it was identified that, the mean score and standard deviation of 
experimental group was 0.004 and 0 respectively, and control group was 0.084 and 
0.099 respectively with the mean difference of 0.08&DOFXODWHGµW¶YDOXHKRXUVDQG
72 hours after the day of injection were 2.11 and 2.857, which was greater than the 
table value (tv= 2.07, df=23) at 0.05 level of significance. Hence it shows there is a 
significant difference in the size of ecchymosis among patients receiving LMWH on 
left thigh, 48 hours and 72 hours after the day of injection. 
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            Hence it shows there is a significant difference in the size of ecchymosis 
between the experimental and control group patients, on right upper outer arm, left 
upper outer arm, right thigh, and left thigh, at 48 hours, 72 hours after dry cold 
application.  
            Effect of dry cold application on ecchymosis, 48 hours after the day of 
injection, it was identified that, the mean score and the standard deviation of 
experimental group was 0.003 and 0 respectively and control group was 0.069 and 
UHVSHFWLYHO\ZLWKWKHPHDQGLIIHUHQFHRI&DOFXODWHGµW¶YDOXHZDV
which was greater than the table value (tv= 2.07, df=23) at 0.05 level of significance. 
Ecchymosis assessed 72 hours after the day of injection, it was identified that, the 
mean score and the standard deviation of experimental group was 0.001 and 0 and 
control group was 0.109 and 0.175 respectively with the mean difference of 0.108. 
&DOFXODWHG µW¶ YDOXH ZDV  ZKLFK ZDV JUHDWHU WKDQ WKH WDEOH YDOXH Wv= 2.07, 
df=23) at 0.05 level of significance. Hence it shows there is a significant difference in 
the size of ecchymosis among patients receiving LMWH in 48hours and 72 hours 
after the day of injection. Thus the research hypothesis H2: There will be a significant 
difference in the size of ecchymosis between the experimental group and control 
group after dry cold application among patients receiving low molecular weight 
heparin is accepted. 
ANNEXURE I  
 
Analysis on the Effect of Dry Cold Application on Pain Perception and 
Ecchymosis in the Experimental and Control Group 
 
 8QSDLUHGµW¶WHVW was used to analyze the effect of dry cold application on 
Pain Perception and Ecchymosis in the experimental and control group  
    t =
SE
xx 21 
  
 
Where,  
 SE (Standard Error) = SD  
21
11
nn
  
 SD (Combined standard deviation) = 
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2
22
2
11

 ¦¦
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xxxx
 
           1X        =  Mean of the experimental group  
          2X    =   Mean of the control group post  
 n1 = Number of samples in experimental group 
 n2 = Number of samples in control group 
  
 
 
 
 
 
ANNEXURE 1.1 
 
Analysis on Effect of Dry Cold Application on Pain Perception among 
Patients Receiving Low Molecular Weight Heparin in Experimental 
Group and Control Group 
 
1.1.1 Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group                
(Right Upper Outer Arm) Immediately after Withdrawing the Needle 
 
 
 
SD = 
   
221
2
22
2
11

 ¦¦
nn
xxxx
   = ට଼Ǥହ଻଻ାଵ଴Ǥହହ଺
ଵଷାଵଶିଶ
     =    0.912 
 
 
SE  = SD 
21
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nn
       =    0.912
12
1
13
1           =      0.365 
 
 t = 
SE
XX 21      = 
365.0
359.5462.1    = 10.677 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 1.33 -0.132 0.017 6.33 0.971 0.943 
2. 1 -0.462 0.213 6.33 0.971 0.943 
3. 1.33 -0.132 0.017 6.33 0.971 0.943 
4. 1.67 0.208 0.043 3.33 -2.029 4.117 
5. 2.33 0.868 0.753 6 0.641 0.411 
6. 1.67 0.208 0.043 4.33 -1.029 1.059 
7. 2.67 1.208 1.459 6 0.641 0.411 
8. 0.33 -1.132 1.281 5.33 -0.029 0.001 
9. 0.67 -0.792 0.627 5 -0.359 0.129 
10. 2.33 0.87 0.757 6 0.641 0.411 
11. 0.33 -1.132 1.281 4.33 -1.029 1.059 
12. 2.67 1.208 1.459 5 -0.359 0.129 
13. 0.67 -0.792 0.627    
 19       8.577 64.31     10.556 
t = 10.677 
1.1.2 Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group                
(Right Upper Outer Arm) After 4 hours 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 1.33 0.637 0.406 
2. 0 0 0 1.33 0.637 0.406 
3. 0 0 0 1.67 0.977 0.955 
4. 0 0 0 0 -0.693 0.48 
5. 0 0 0 1.33 0.637 0.406 
6. 0 0 0 0 -0.693 0.48 
7. 0 0 0 0 -0.693 0.48 
8. 0 0 0 0.33 -0.363 0.132 
9. 0 0 0 0.33 -0.363 0.132 
10. 0 0 0 1.33 0.637 0.406 
11. 0 0 0 0 -0.693 0.48 
12. 0 0 0 0.67 -0.023 0.001 
13. 0 0 0    
 0          0 8.32  4.764 
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   = ට଴ାସǤ଻଺ସ
ଵଷାଵଶିଶ
     =    0.455 
 
 
SE  = SD 
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 t = 
SE
XX 21      = 
182.0
693.00    =   3.808 
  
 
 
t = 3.808 
1.1.3 Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group               
(Right Upper Outer Arm) After 8 hours 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 0 -0.222 0.049 
2. 0 0 0 0.33 0.108 0.012 
3. 0 0 0 0.33 0.108 0.012 
4. 0 0 0 0 -0.222 0.049 
5. 0 0 0 0.67 0.448 0.201 
6. 0 0 0 0 -0.222 0.049 
7. 0 0 0 0 -0.222 0.049 
8. 0 0 0 0 -0.222 0.049 
9. 0 0 0 0.33 -20.3 0.012 
10. 0 0 0 0.33 0.108 0.012 
11. 0 0 0 0 0.108 0.049 
12. 0 0 0  0.67 -0.222 0.201 
13. 0 0 0  0.448  
 0     0 2.66  0.744 
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   = ට଴ା଴Ǥ଻ସସ
ଵଷାଵଶିଶ
     =    0.179 
 
 
SE  = SD 
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 t = 
SE
XX 21      = 
072.0
222.00    =   3.083 
  
 
 
t = 3.083 
1.1.4  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group               
(Left Upper Outer Arm) Immediately after Withdrawing the Needle 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 2.33 0.633 0.439 5.33 -0.558 0.311 
2. 2 0.333 0.111 4.33 -1.558 2.427 
3. 0.67 -0.997 0.994 6.33 0.442 0.195 
4. 2 0.333 0.111 4.67 -1.218 1.484 
5. 3 1.333 1.777 6.67 0.782 0.612 
6. 3.67 2.003 4.012 5.67 -0.218 0.048 
7. 2.33 0.663 0.439 8.33 2.442 5.963 
8. 0.33 -1.337 1.787 8 2.112 4.461 
9. 0.67 -0.997 0.994 6 0.112 0.013 
10. 2 0.333 0.111 5.67 -0.218 0.048 
11. 0.67 -0.997 0.994 5.33 -0.558 0.311 
12. 0.67 -0.997 0.994 4.33 -1.558 2.427 
13. 1.33 -0.337 0.114    
 21.67     12.877 70.66  18.3 
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ଵଷାଵଶିଶ
     =    1.164 
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 t = 
SE
XX 21      = 
466.0
888.5667.1    = 9.058 
  
 
 
t = 9.058 
1.1.5 Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group                
(Left Upper Outer Arm) After 4 hours 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 0.33 -0.586 0.343 
2. 0 0 0 0 -0.916 0.839 
3. 0 0 0 0.33 -0.586 0.343 
4. 0 0 0 1 0.084 0.007 
5. 0 0 0 1.33 0.414 0.171 
6. 0 0 0 1 0.084 0.007 
7. 0 0 0 2 1.084 1.175 
8. 0 0 0 2.33 1.414 1.999 
9. 0 0 0 1.33 0.414 0.171 
10. 0 0 0 0.67 -0.246 0.061 
11. 0 0 0 0.67 -0.246 0.061 
12. 0 0 0 0 -0.916 0.839 
13. 0 0 0    
 0          0 10.99  6.016 
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 t = 
SE
XX 21      = 
205.0
916.00    =   4.468 
  
 
 
 
t = 4.468 
1.1.6  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group         
(Left Upper Outer Arm) After 8 hours 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 0 -0.306 0.094 
2. 0 0 0 0 -0.306 0.094 
3. 0 0 0 0.33 0.024 0.001 
4. 0 0 0 0 -0.306 0.094 
5. 0 0 0 0 -0.306 0.094 
6. 0 0 0 0.67 -0.364 0.132 
7. 0 0 0 1 -0.694 0.482 
8. 0 0 0 1 -0.694 0.482 
9. 0 0 0 0 -0.306 0.094 
10. 0 0 0 0 -0.306 0.094 
11. 0 0 0 0.67 0.364 0.132 
12. 0 0 0 0 -0.306 0.094 
13. 0 0 0    
 0     0 3.67  1.887 
 
 
SD = 
   
221
2
22
2
11

 ¦¦
nn
xxxx
   = ට଴ାଵǤ଼଼଻
ଵଷାଵଶିଶ
     =    0.286 
 
 
SE  = SD 
21
11
nn
       =    0.286
12
1
13
1           =      0.114 
 
 t = 
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XX 21      = 
114.0
306.00    =   2.684 
  
 
 
t = 2.684 
1.1.7  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group              
(Right Thigh) Immediately after Withdrawing the Needle 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 1.5 0.269 0.072 3.5 -1.75 3.061 
2. 0 -1.231 1.515 5 -0.25 0.063 
3. 1.5 0.269 0.072 5.5 0.25 0.063 
4. 2 0.769 0.591 4 -1.25 1.563 
5. 1.5 0.269 0.072 8.5 3.25 10.563 
6. 2.5 1.269 1.61 4 -1.25 1.563 
7. 2.5 1.269 1.61 5 -0.25 0.063 
8. 0 -1.231 1.515 6.5 1.25 1.563 
9. 1 -0.231 0.053 4.5 -0.75 0.563 
10. 3.5 2.269 5.148 5.5 0.25 0.063 
11. 0 -1.231 1.515 5.5 0.25 0.063 
12. 0 -1.231 1.515 5.5 0.25 0.063 
13. 0 -1.231 1.515    
 16     16.803 63  19.254 
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 t = 
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XX 21      = 
501.0
25.5231.1    = 8.023 
  
 
 
 
 
t = 8.023 
1.1.8  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group           
(Right Thigh) After 4 hours 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 0 -0.708 0.501 
2. 0 0 0 0.5 -0.208 0.043 
3. 0 0 0 0 -0.708 0.501 
4. 0 0 0 0.5 -0.208 0.043 
5. 0 0 0 3 2.292 5.253 
6. 0 0 0 0 -0.708 0.501 
7. 0 0 0 0 -0.708 0.501 
8. 0 0 0 1 0.292 0.085 
9. 0 0 0 0 -0.708 0.501 
10. 0 0 0 1 0.292 0.085 
11. 0 0 0 1 0.292 0.085 
12. 0 0 0 1.5 0.792 0.627 
13. 0 0 0    
 0          0 8.5  8.726 
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t = 2.878 
1.1.9  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group            
(Right Thigh) After 8 hours 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 0 -0.375 0.141 
2. 0 0 0 0 -0.375 0.141 
3. 0 0 0 0 -0.375 0.141 
4. 0 0 0 0 -0.375 0.141 
5. 0 0 0 2 1.625 2.641 
6. 0 0 0 0 -0.375 0.141 
7. 0 0 0 0 -0.375 0.141 
8. 0 0 0 0.5 0.125 0.016 
9. 0 0 0 0 -0.375 0.141 
10. 0 0 0 0.5 0.125 0.016 
11. 0 0 0 0.5 0.125 0.016 
12. 0 0 0 1 0.625 0.391 
13. 0 0 0    
 0     0 4.5  4.067 
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 t = 
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t = 2.232 
1.1.10  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group             
(Left Thigh) Immediately after Withdrawing the Needle 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 2 0.654 0.428 7.5 1.667 2.779 
2. 3.5 2.154 4.639 5 -0.833 0.694 
3. 0 -1.346 1.812 4.5 -1.333 1.777 
4. 0.5 -0.846 0.716 4 -1.833 3.359 
5. 1.5 0.154 0.024 7.5 1.667 2.779 
6. 0 -1.346 1.812 4 -1.833 3.359 
7. 3.5 2.154 4.639 5.5 -0.333 0.111 
8. 0 -1.346 1.812 6.5 0.667 0.445 
9. 1 -0.346 0.119 6.5 0.667 0.445 
10. 2.5 1.154 1.332 7 1.167 1.362 
11. 1.5 0.154 0.024 7 1.167 1.362 
12. 0.5 -0.846 0.716 5 -0.833 0.694 
13. 1 -0.346 0.119    
 17.5     18.192 70  19.166 
 
SD = 
   
221
2
22
2
11

 ¦¦
nn
xxxx
   = ටଵ଼ǤଵଽଶାଵଽǤଵ଺଺
ଵଷାଵଶିଶ
     =    1.275 
 
 
SE  = SD 
21
11
nn
       =    1.275
12
1
13
1           =      0.51 
 
 t = 
SE
XX 21      = 
51.0
833.5346.1    = 8.798 
  
 
 
 
 
t = 8.798 
1.1.11  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group             
(Left Thigh) After 4 hours 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 2.5 1.292 1.669 
2. 0 0 0 0 -1.208 1.459 
3. 0 0 0 0.5 -0.708 0.501 
4. 0 0 0 0.5 -0.708 0.501 
5. 0 0 0 1.5 0.292 0.085 
6. 0 0 0 1 -0.208 0.043 
7. 0 0 0 1 -0.208 0.043 
8. 0 0 0 2 0.792 0.627 
9. 0 0 0 2 0.792 0.627 
10. 0 0 0 2 0.792 0.627 
11. 0 0 0 1.5 0.292 0.085 
12. 0 0 0 0 -1.208 1.459 
13. 0 0 0    
 0  0 14.5  7.726 
 
SD = 
   
221
2
22
2
11

 ¦¦
nn
xxxx
   = ට଴ା଻Ǥ଻ଶ଺
ଵଷାଵଶିଶ
     =    0.579 
 
 
SE  = SD 
21
11
nn
       =    0.579
12
1
13
1           =      0.232 
 
 t = 
SE
XX 21      = 
232.0
208.10    =   5.207 
  
 
 
t = 5.207 
1.1.12  Effect of Dry Cold Application on Pain Perception among Patients 
Receiving LMWH in Experimental Group and Control Group                   
(Left Thigh) After 8 hours 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 1 0.708 0.501 
2. 0 0 0 0 -0.292 0.085 
3. 0 0 0 0 -0.292 0.085 
4. 0 0 0 0 -0.292 0.085 
5. 0 0 0 0 -0.292 0.085 
6. 0 0 0 0 -0.292 0.085 
7. 0 0 0 0.5 0.208 0.043 
8. 0 0 0 1 0.708 0.501 
9. 0 0 0 0.5 0.208 0.043 
10. 0 0 0 0 -0.292 0.085 
11. 0 0 0 0.5 0.208 0.043 
12. 0 0 0 0 -0.292 0.085 
13. 0 0 0    
 0     0 3.5       1.726 
 
SD = 
   
221
2
22
2
11

 ¦¦
nn
xxxx
   = ට ଴ାଵǤ଻ଶ଺
ଵଷାଵଶିଶ
     =    0.274 
 
 
SE  = SD 
21
11
nn
       =    0.274
12
1
13
1           =      0.109 
 
 t = 
SE
XX 21      = 
109.0
292.00    =   2.679 
  
 
 
 
t = 2.679 
ANNEXURE 1.2 
 
 Analysis on Effect of Dry Cold Application on Pain Perception among 
Patients Receiving Low Molecular Weight Heparin in Experimental Group 
and Control Group 
 
1.2.1  Effect of Dry Cold Application on Pain Perception Immediately after 
Withdrawing the Needle among Patients Receiving LMWH in 
Experimental Group and Control Group 
 
 
 
SD = 
   
221
2
22
2
11

 ¦¦
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xxxx
   = ටସǤ଴଴ହାହହǤ଻ଵହ
ଵଷାଵଶିଶ
     =    1.612 
 
 
SE  = SD 
21
11
nn
       =    1.612 
12
1
13
1           =      0.645 
 
 t = 
SE
XX 21      = 
645.0
861.1439.0    = 2.205 
 
 
S. No 
Experimental Group Control Group 
x1 111 Dxx    D12 x2 222 Dxx    D22 
1. 1.462 1.023 1.047 5.359 3.498 12.236 
2. 1.667 1.228 1.508 5.888 4.027 16.217 
3. 1.231 0.792 0.627 5.25 3.389 11.485 
4. 1.346 0.907 0.823 5.833 3.972 15.777 
 5.706  4.005 22.33  55.715 
t = 2.205 
1.2.2   Effect of Dry Cold Application on Pain Perception after 4 hours 
among Patients Receiving LMWH in Experimental Group and 
Control Group 
 
 
SD = 
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2
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xxxx
   = ට଴ାଵǤହହଶ
ଵଷାଵଶିଶ
     =    0.261 
 
 
SE  = SD 
21
11
nn
       =    0.261
12
1
13
1           =      0.104 
 
 t = 
SE
XX 21      = 
104.0
294.0.0    = 2.827 
 
 
 
 
 
 
 
S. No 
Experimental Group Control Group 
x1 111 Dxx    D12 x2 222 Dxx    D22 
1. 0 0 0 0.693 0.399 0.159 
2. 0 0 0 0.916 0.622 0.387 
3. 0 0 0 0.708 0.414 0.171 
4. 0 0 0 1.208 0.914 0.835 
 0 0 0 3.525  1.552 
t = 2.827 
1.2.3  Effect of Dry Cold Application on Pain Perception after 8 hours 
among Patients Receiving LMWH in Experimental Group and 
Control Group 
 
 
SD = 
   
221
2
22
2
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 ¦¦
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xxxx
   = ට଴ା଴Ǥଵ଻ଵ
ଵଷାଵଶିଶ
     =    0.084 
 
 
SE  = SD 
21
11
nn
       =    0.084 
12
1
13
1           =      0.034 
 
 t = 
SE
XX 21      = 
034.0
099.00    = 2.912 
 
 
 
 
 
 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 0.222 0.123 0.015 
2. 0 0 0 0.306 0.207 0.043 
3. 0 0 0 0.375 0.276 0.076 
4. 0 0 0 0.292 0.193 0.037 
 0 0 0 1.195  0.171 
t = 2.912 
ANNEXURE 2.1 
 
 Analysis on Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving Low Molecular Weight Heparin in Experimental Group and 
Control Group 
 
2.1.1  Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group               
(Right Upper Outer Arm) 48 hours after the day of injection 
 
 
 
 
SD = 
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2
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2
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
 ¦¦
nn
xxxx
   = ට଴ାଵǤଽସସ
ଵଷାଵଶିଶ
     =    0.292 
 
 
SE  = SD 
21
11
nn
       =    0.292
12
1
13
1           =      0.117 
 
 t = 
SE
XX 21      = 
117.0
329.0005.0    = 2.769 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 -0.005 0 0.025 -0.304 0.092 
2. 0 -0.005 0 0.025 -0.304 0.092 
3. 0 -0.005 0 1.42 1.091 1.19 
4. 0.02 0.015 0 0.01 -0.319 0.102 
5. 0 -0.005 0 0.355 0.026 0.001 
6. 0 -0.005 0 0.8 0.471 0.222 
7. 0.02 0.015 0 0.105 -0.224 0.05 
8. 0.005 0 0 0.15 -0.179 0.032 
9. 0 -0.005 0 0.6 0.271 0.073 
10. 0.01 0.005 0 0.18 -0.149 0.022 
11. 0 -0.005 0 0.15 -0.179 0.032 
12. 0.005 0 0 0.138 -0.191 0.036 
13. 0.005 0 0    
 0.065  0 3.958  1.944 
t = 2.769 
2.1.2  Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group                
(Right Upper Outer Arm) 72 hours after the day of injection 
 
 
 
SD = 
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2
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xxxx
   = ට଴ା଺Ǥ଴ହଽ
ଵଷାଵଶିଶ
     =    0.513 
 
 
SE  = SD 
21
11
nn
       =    0.513
12
1
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1           =      0.205 
 
 t = 
SE
XX 21      = 
205.0
515.0003.0    = 2.498 
 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 -0.003 0 0.06 -0.455 0.207 
2. 0 -0.003 0 0.05 -0.465 0.216 
3. 0 -0.003 0 2.6 2.085 4.347 
4. 0.005 0.002 0 0.07 -0.445 0.198 
5. 0 -0.003 0 0.52 0.005 0 
6. 0 -0.003 0 1.175 0.66 0.436 
7. 0.01 0.007 0 0.025 -0.49 0.24 
8. 0.005 0.002 0 0.325 -0.19 0.036 
9. 0 -0.003 0 0.765 0.25 0.063 
10. 0.005 0.002 0 0.105 -0.41 0.168 
11. 0 -0.003 0 0.275 -0.24 0.058 
12. 0.005 0.002 0 0.215 -0.3 0.09 
13. 0.005 0.002 0    
 0.035  0 6.185        6.059 
t = 2.498 
2.1.3  Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group (Left 
Upper Outer Arm) 48 hours after the day of injection 
 
 
SD = 
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2
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 ¦¦
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xxxx
   = ට଴ାଷǤଵଷସ
ଵଷାଵଶିଶ
     =    0.369 
 
 
SE  = SD 
21
11
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       =    0.369
12
1
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1           =      0.148 
 
 t = 
SE
XX 21      = 
148.0
331.0007.0    = 2.189 
 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0.01 -0.003 0 0.025 -0.306 0.094 
2. 0.01 -0.003 0 0.43 0.099 0.009 
3. 0.01 -0.003 0 1.7 1.369 1.874 
4. 0 -0.007 0 0.055 -0.276 0.076 
5. 0.005 -0.002 0 0.08 -0.251 0.063 
6. 0 -0.003 0 0.06 -0.271 0.073 
7. 0.01 -0.003 0 0.025 -0.306 0.094 
8. 0.02 0.013 0 0.043 -0.288 0.083 
9. 0 -0.007 0 1.125 0.794 0.63 
10. 0.01 -0.003 0 0.288 -0.043 0.002 
11. 0.01 -0.003 0 0.058 -0.273 0.075 
12. 0 -0.007 0 0.085 -0.246 0.061 
13. 0 -0.007 0    
 0.085  0 3.974       3.134 
t = 2.189 
2.1.4   Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group                  
(Left Upper Outer Arm) 72 hours after the day of injection 
 
 
SD = 
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2
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 ¦¦
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xxxx
   = ට଴ା଺Ǥସ଼ଽ
ଵଷାଵଶିଶ
     =    0.531 
 
 
SE  = SD 
21
11
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       =    0.531
12
1
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1           =      0.212 
 
 t = 
SE
XX 21      = 
212.0
552.0003.0    = 2.589 
 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0.005 0.002 0 0.035 -0.517 0.267 
2. 0.005 0.002 0 0.575 0.023 0.001 
3. 0 -0.003 0 2.625 2.073 4.297 
4. 0 -0.003 0 0.255 -0.297 0.088 
5. 0 -0.003 0 0.17 -0.382 0.146 
6. 0 -0.003 0 0.08 -0.472 0.223 
7. 0.005 0.002 0 0.045 -0.507 0.257 
8. 0.02 0.017 0 0.275 -0.277 0.077 
9. 0 -0.003 0 1.5 0.948 0.899 
10. 0 -0.003 0 0.45 -0.102 0.01 
11. 0 -0.003 0 0.53 -0.022 0.001 
12. 0 -0.003 0 0.08 -0.472 0.223 
13. 0 -0.003 0    
 0.035  0 6.62  6.489 
t = 2.589 
2.1.5   Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group              
(Right Thigh) 48 hours after the day of injection 
 
 
 
SD = 
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   = ට଴Ǥ଴଴ଵା଴Ǥଵଷଷ
ଵଷାଵଶିଶ
     =    0.076 
 
 
SE  = SD 
21
11
nn
       =    0.076
12
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1           =      0.03 
 
 t = 
SE
XX 21      = 
03.0
119.0009.0    = 3.667 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 -0.009 0 0.02 -0.099 0.009 
2. 0 -0.009 0 0.25 0.131 0.017 
3. 0 -0.009 0 0.09 -0.029 0.001 
4. 0.01 0.001 0 0.35 0.231 0.053 
5. 0 -0.009 0 0.02 -0.099 0.009 
6. 0.06 0.051 0 0.04 -0.079 0.006 
7. 0 -0.009 0 0.09 -0.029 0.001 
8. 0 -0.009 0 0.0875 -0.0315 0.001 
9. 0 -0.009 0 0.01 -0.109 0.012 
10. 0 -0.009 0 0.04 -0.079 0.006 
11. 0 -0.009 0 0.225 0.106 0.011 
12. 0.015 0.006 0 0.2 0.081 0.007 
13. 0.04 0.031 0.001    
 0.125  0.001 1.4225  0.133 
t = 3.667 
2.1.6   Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group          
(Right Thigh) 72 hours after the day of injection 
 
 
 
SD = 
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   = ට଴Ǥ଴଴ଵା଴Ǥସଵଵ
ଵଷାଵଶିଶ
     =    0.134 
 
 
SE  = SD 
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       =    0.134
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1           =      0.054 
 
 t = 
SE
XX 21      = 
054.0
16.0005.0    = 2.87 
 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 -0.005 0 0.04 -0.12 0.014 
2. 0 -0.005 0 0.3 0.14 0.019 
3. 0 -0.005 0 0.04 -0.12 0.014 
4. 0.01 0.005 0 0.7 0.54 0.292 
5. 0 -0.005 0 0.02 -0.14 0.019 
6. 0.04 0.035 0.001 0.09 -0.07 0.005 
7. 0 -0.005 0 0.09 -0.07 0.005 
8. 0 -0.005 0 0.105 -0.055 0.003 
9. 0 -0.005 0 0.01 -0.15 0.023 
10. 0 -0.005 0 0.075 -0.085 0.007 
11. 0 -0.005 0 0.25 0.09 0.008 
12. 0.01 0.005 0 0.2 0.04 0.002 
13. 0.01 0.005 0    
 0.07  0.001 1.92       0.411 
t = 2.87 
2.1.7   Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group (Left 
Thigh) 48 hours after the day of injection 
 
 
 
SD = 
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   = ට଴Ǥ଴଴ଵା଴Ǥ଴ସହ
ଵଷାଵଶିଶ
     =    0.045 
 
 
SE  = SD 
21
11
nn
       =    0.045
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1
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1           =      0.018 
 
 t = 
SE
XX 21      = 
018.0
046.0008.0    = 2.11 
 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 -0.008 0 0.015 -0.031 0.001 
2. 0 -0.008 0 0.04 -0.006 0 
3. 0 -0.008 0 0.01 -0.036 0.001 
4. 0.01 0.002 0 0.0225 -0.0235 0.001 
5. 0 -0.008 0 0.01 -0.036 0.001 
6. 0.02 0.012 0 0.2 0.154 0.024 
7. 0 -0.008 0 0.01 -0.036 0.001 
8. 0.04 0.032 0.001 0.0225 -0.0235 0.001 
9. 0 -0.008 0 0.01 -0.036 0.001 
10. 0.01 0.002 0 0.015 -0.031 0.001 
11. 0 -0.008 0 0.16 0.114 0.013 
12. 0.015 0.007 0 0.04 -0.006 0 
13. 0.01 0.002 0    
 0.105      0.001 0.555  0.045 
t = 2.11 
2.1.8   Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group               
(Left Thigh) 72 hours after the day of injection 
 
 
 
SD = 
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   = ට଴ା଴Ǥଵଵଶ
ଵଷାଵଶିଶ
     =    0.071 
 
 
SE  = SD 
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11
nn
       =    0.071 
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1           =      0.028 
 
 t = 
SE
XX 21      = 
028.0
084.0004.0    = 2.857 
 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 -0.004 0 0.03 -0.054 0.003 
2. 0 -0.004 0 0.09 0.006 0 
3. 0 -0.004 0 0.01 -0.074 0.005 
4. 0.01 0.006 0 0.03 -0.054 0.003 
5. 0 -0.004 0 0.015 -0.069 0.005 
6. 0.02 0.016 0 0.36 0.276 0.076 
7. 0 -0.004 0 0.04 -0.044 0.002 
8. 0.01 0.006 0 0.04 -0.044 0.002 
9. 0 -0.004 0 0.075 -0.009 0 
10. 0 -0.004 0 0.04 -0.044 0.002 
11. 0 -0.004 0 0.2 0.116 0.014 
12. 0 -0.004 0 0.075 -0.009 0 
13. 0.01 0.006 0    
 0.05  0 1.005       0.112 
t = 2.857 
ANNEXURE 2.2 
 
 Analysis on Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving Low Molecular Weight Heparin in Experimental Group and 
Control Group 
 
2.2.1   Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group           
48 hours after the day of injection 
 
 
SD = 
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   = ට଴ା଴Ǥଵସଵ
ଵଷାଵଶିଶ
     =    0.078 
 
 
SE  = SD 
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       =    0.078 
12
1
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1           =      0.031 
 
 t = 
SE
XX 21      = 
031.0
069.0003.0    = 2.129 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0.005 0.002 0 0.33 0.261 0.068 
2. 0.02 0.017 0 0.331 0.262 0.069 
3. 0.009 0.006 0 0.119 0.05 0.003 
4. 0.008 0.005 0 0.046 -0.023 0.001 
 0.042  0 0.826  0.141 
t = 2.129 
2.2.2  Effect of Dry Cold Application on Ecchymosis among Patients 
Receiving LMWH in Experimental Group and Control Group 
Ecchymosis 72 hours after the day of injection 
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   = ට଴ା଴Ǥଷ଺଺
ଵଷାଵଶିଶ
     =    0.127 
 
 
SE  = SD 
21
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       =    0.127 
12
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1           =      0.051 
 
 t = 
SE
XX 21      = 
051.0
109.0001.0    = 2.118 
 
 
 
 
 
 
S. No 
Experimental Group Control Group 
x1 
111 Dxx    D1
2 x2 
222 Dxx    D2
2 
1. 0 0 0 0.516 0.407 0.166 
2. 0 0 0 0.552 0.443 0.196 
3. 0 0 0 0.16 0.051 0.003 
4. 0 0 0 0.084 -0.025 0.001 
 0         0 1.312  0.366 
t = 2.118 
ANNEXURE 3.1 
Content Validity of the Tool 
S. 
No 
ITEM 
EXPERT NUMBER OF 
AGREEMENT 
I-CVI 
1 2 3 4 5 6 7 
 
 
 
1. 
Section A 
Demographic 
Variables 
Age 3 4 4 3 4 3 4 7 0.98 
2. Gender 3 4 4 4 4 3 4 7 0.98 
3. Educational Status 3 4 4 4 4 3 4 7 0.98 
4. Marital  Status 3 4 4 4 4 3 4 7 0.98 
5. Religion 2 4 4 4 4 3 4 7 0.98 
6. Occupation 2 4 4 4 4 3 4 7 0.98 
 
 
1. 
Section B 
Clinical Variables 
Diagnosis 3 4 3 4 4 3 4 7 0.98 
2. Name of the 
injection and dose      
4 4 3 4 4 3 4 7 0.98 
3. Frequency of          
Inj. LMWH 
4 4 4 4 3 3 4 7 0.98 
4. Any other illness 4 4 4 4 2 3 4 7 0.98 
 
1. 
Section C 
Numerical pain 
rating scale 
4 4 4 4 4 3 4 7 0.98 
 
1. 
Section D 
Transparent ruler 
scale 
4 4 4 3 4 3 4 7 0.98 
 
CONTROL GROUP 
ECCHYMOSIS AFTER 48 HOURS OF  
LMWH INJECTION  
 
 
 
ECCHYMOSIS AFTER 72 HOURS OF  
LMWH INJECTION  
 
 
  
EXPERIMENTAL GROUP  
EFFECT OF DRY COLD APPLICATION ON 
ECCHYMOSIS AFTER 48 HOURS OF  
LMWH INJECTION  
 
 
 
EFFECT OF DRY COLD APPLICATION ON 
ECCHYMOSIS AFTER 72 HOURS OF  
LMWH INJECTION  
 
